  ('OV_3529','Adenovirus','Adenovirus GD55','DNA','Adenoviridae','GOLPH2 regulated aoncolytic adenovirus','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','Du145','5000 cells per well','NA','MTT assay','20 MOI','20% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3530','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Deletion in E1B55 viral protein','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','LNCaP','5000 cells per well','NA','MTT assay','1 MOI','60% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3531','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Deletion in E1B55 viral protein','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','LNCaP','5000 cells per well','NA','MTT assay','5 MOI','45% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3532','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Deletion in E1B55 viral protein','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','LNCaP','5000 cells per well','NA','MTT assay','10 MOI','30% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3533','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Deletion in E1B55 viral protein','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','LNCaP','5000 cells per well','NA','MTT assay','20 MOI','18% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3534','Adenovirus','Adenovirus GD55','DNA','Adenoviridae','GOLPH2 regulated aoncolytic adenovirus','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','LNCaP','5000 cells per well','NA','MTT assay','1 MOI','45% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3535','Adenovirus','Adenovirus GD55','DNA','Adenoviridae','GOLPH2 regulated aoncolytic adenovirus','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','LNCaP','5000 cells per well','NA','MTT assay','5 MOI','20% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3536','Adenovirus','Adenovirus GD55','DNA','Adenoviridae','GOLPH2 regulated aoncolytic adenovirus','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','LNCaP','5000 cells per well','NA','MTT assay','10 MOI','20% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3537','Adenovirus','Adenovirus GD55','DNA','Adenoviridae','GOLPH2 regulated aoncolytic adenovirus','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','LNCaP','5000 cells per well','NA','MTT assay','20 MOI','15% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3538','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Deletion in E1B55 viral protein','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','1 MOI','90% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3539','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Deletion in E1B55 viral protein','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','5 MOI','80% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3540','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Deletion in E1B55 viral protein','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','10 MOI','70% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3541','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Deletion in E1B55 viral protein','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','20 MOI','58% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3542','Adenovirus','Adenovirus GD55','DNA','Adenoviridae','GOLPH2 regulated aoncolytic adenovirus','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3543','Adenovirus','Adenovirus GD55','DNA','Adenoviridae','GOLPH2 regulated aoncolytic adenovirus','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','5 MOI','50% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3544','Adenovirus','Adenovirus GD55','DNA','Adenoviridae','GOLPH2 regulated aoncolytic adenovirus','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','10 MOI','40% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3545','Adenovirus','Adenovirus GD55','DNA','Adenoviridae','GOLPH2 regulated aoncolytic adenovirus','Yes','No','No','Shanghai cell collection','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','20 MOI','30% cell viability','No','No','NA','No response','NA','Induction of apoptosis as measured by TUNEL assay','NA','NA','28880012'),
  ('OV_3546','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','5 MOI','98% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3547','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','5 MOI','90% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3548','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','5 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3549','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','5 MOI','45% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3550','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','10 MOI','98% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3551','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','10 MOI','90% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3552','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','10 MOI','50% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3553','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','10 MOI','25% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3554','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','15 MOI','95% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3555','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','15 MOI','80% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3556','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','15 MOI','40% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3557','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','15 MOI','20% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3558','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','5 MOI','60% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3559','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','5 MOI','18% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3560','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','5 MOI','17% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3561','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','5 MOI','Complete cell death after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3562','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','10 MOI','58% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3563','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','10 MOI','16% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3564','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','10 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3565','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','10 MOI','Complete cell death after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3566','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','15 MOI','58% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3567','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','15 MOI','16% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3568','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','15 MOI','5% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3569','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW620','5000 cells per well','NA','MTT assay','15 MOI','Complete cell death after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3570','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','5 MOI','98% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3571','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','5 MOI','80% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3572','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','5 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3573','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','5 MOI','70% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3574','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','10 MOI','98% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3575','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','10 MOI','70% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3576','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','10 MOI','60% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3577','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','10 MOI','55% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3578','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','15 MOI','95% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3579','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','15 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3580','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','15 MOI','50% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3581','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','15 MOI','40% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3582','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','5 MOI','70% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3583','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','5 MOI','50% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3584','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','5 MOI','20% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3585','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','5 MOI','20% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3586','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','10 MOI','70% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3587','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','10 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3588','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','10 MOI','10% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3589','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','10 MOI','10% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3590','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','15 MOI','60% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3591','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','15 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3592','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','15 MOI','10% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3593','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','SW480','5000 cells per well','NA','MTT assay','15 MOI','8% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3594','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','5 MOI','98% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3595','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','5 MOI','85% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3596','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','5 MOI','98% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3597','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','5 MOI','98% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3598','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','10 MOI','98% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3599','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','10 MOI','70% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3600','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','10 MOI','90% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3601','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','10 MOI','80% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3602','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','15 MOI','98% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3603','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','15 MOI','70% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3604','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','15 MOI','90% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3605','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','Yes','No','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','15 MOI','60% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3606','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','5 MOI','70% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3607','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','5 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3608','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','5 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3609','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','5 MOI','50% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3610','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','10 MOI','70% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3611','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','10 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3612','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','10 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3613','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','10 MOI','50% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3614','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','15 MOI','60% cell viability after 24 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3615','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','15 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3616','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','15 MOI','40% cell viability after 72 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3617','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (25 micromolar)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','5000 cells per well','NA','MTT assay','15 MOI','22% cell viability after 96 hours','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3618','Adenovirus','Adenovirus CD55-TRAIL','DNA','Adenoviridae','Virus expressingTRAIL gene','No','Virus in combination with luteolin (50mg/kg)','No','Shanghai cell collection','Human colorectal cancer cell line','HT-29','NA','NA','NA','NA','NA','Balb/c nude mice xenograft for HT29 cell line (8.0E+6)','2.0E+9 pfu','NA','Decrease in tumor volume to below 2000mm after 30 days comapred to control 4000mm','Intratumoral','Virus in combination with induce apiptosis in cancer cell','NA','NA','29039580'),
  ('OV_3619','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','1 MOI','60% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3620','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','1 MOI','20% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3621','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','60% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3622','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','20% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3623','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human liver cancer cell line','HepG2','5000 cells per well','NA','MTT assay','1 MOI','60% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3624','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human liver cancer cell line','HepG2','5000 cells per well','NA','MTT assay','1 MOI','20% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3625','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human liver cancer cell line','Huh-4','5000 cells per well','NA','MTT assay','1 MOI','60% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3626','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human liver cancer cell line','Huh-4','5000 cells per well','NA','MTT assay','1 MOI','10% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3627','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human gastric cancer cell line','KATO III','5000 cells per well','NA','MTT assay','1 MOI','90% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3628','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human gastric cancer cell line','KATO III','5000 cells per well','NA','MTT assay','1 MOI','60% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3629','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','H358','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3630','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','H358','5000 cells per well','NA','MTT assay','1 MOI','30% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3631','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','H-1299','5000 cells per well','NA','MTT assay','1 MOI','30% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3632','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','H-1299','5000 cells per well','NA','MTT assay','1 MOI','5% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3633','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','1 MOI','60% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3634','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','1 MOI','10% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3635','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','100% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3636','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','100% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3637','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human liver cancer cell line','HepG2','5000 cells per well','NA','MTT assay','1 MOI','100% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3638','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human liver cancer cell line','HepG2','5000 cells per well','NA','MTT assay','1 MOI','100% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3639','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human liver cancer cell line','Huh-4','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3640','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human liver cancer cell line','Huh-4','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3641','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human gastric cancer cell line','KATO III','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3642','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human gastric cancer cell line','KATO III','5000 cells per well','NA','MTT assay','1 MOI','30% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3643','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','H358','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3644','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','H358','5000 cells per well','NA','MTT assay','1 MOI','15% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3645','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','H-1299','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3646','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lung cancer cell line','H-1299','5000 cells per well','NA','MTT assay','1 MOI','20% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3647','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','1 MOI','30% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3648','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human prostate cancer cell line','PC-3','5000 cells per well','NA','MTT assay','1 MOI','12% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3649','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3650','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','18% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3651','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human liver cancer cell line','HepG2','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3652','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human liver cancer cell line','HepG2','5000 cells per well','NA','MTT assay','1 MOI','18% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3653','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human liver cancer cell line','Huh-4','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3654','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human liver cancer cell line','Huh-4','5000 cells per well','NA','MTT assay','1 MOI','12% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3655','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human gastric cancer cell line','KATO III','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3656','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human gastric cancer cell line','KATO III','5000 cells per well','NA','MTT assay','1 MOI','20% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3657','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human lung cancer cell line','H358','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3658','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human lung cancer cell line','H358','5000 cells per well','NA','MTT assay','1 MOI','5% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3659','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human lung cancer cell line','H-1299','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3660','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human lung cancer cell line','H-1299','5000 cells per well','NA','MTT assay','1 MOI','Complete cell death after 6 days','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3661','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human cervix cancer cell line','HeLa','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3662','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human cervix cancer cell line','HeLa','5000 cells per well','NA','MTT assay','1 MOI','68% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3663','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human cervix cancer cell line','SIHA','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3664','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human cervix cancer cell line','SIHA','5000 cells per well','NA','MTT assay','1 MOI','15% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3665','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human nasopharyngeal cell line','HK-1','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3666','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human nasopharyngeal cell line','HK-1','5000 cells per well','NA','MTT assay','1 MOI','5% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3667','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human nasopharyngeal cell line','HONE-1','5000 cells per well','NA','MTT assay','1 MOI','30% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3668','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human nasopharyngeal cell line','HONE-1','5000 cells per well','NA','MTT assay','1 MOI','20% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3669','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human eosopahgeal cancer cell line','EC109','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3670','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human eosopahgeal cancer cell line','EC109','5000 cells per well','NA','MTT assay','1 MOI','60% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3671','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human eosopahgeal cancer cell line','KYSE 70','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3672','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human eosopahgeal cancer cell line','KYSE 70','5000 cells per well','NA','MTT assay','1 MOI','25% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3673','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human colon cancer cell line','HT-29','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3674','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human colon cancer cell line','HT-29','5000 cells per well','NA','MTT assay','1 MOI','10% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3675','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human colon cancer cell line','HCT-116','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3676','Measles virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human colon cancer cell line','HCT-116','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3677','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human cervix cancer cell line','HeLa','5000 cells per well','NA','MTT assay','1 MOI','100% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3678','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human cervix cancer cell line','HeLa','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3679','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human cervix cancer cell line','SIHA','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3680','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human cervix cancer cell line','SIHA','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3681','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human nasopharyngeal cell line','HK-1','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3682','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human nasopharyngeal cell line','HK-1','5000 cells per well','NA','MTT assay','1 MOI','Complete cell death after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3683','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human nasopharyngeal cell line','HONE-1','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3684','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human nasopharyngeal cell line','HONE-1','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3685','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human eosopahgeal cancer cell line','EC109','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3686','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human eosopahgeal cancer cell line','EC109','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3687','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human eosopahgeal cancer cell line','KYSE 70','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3688','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human eosopahgeal cancer cell line','KYSE 70','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3689','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human colon cancer cell line','HT-29','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3690','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human colon cancer cell line','HT-29','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3691','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human colon cancer cell line','HCT-116','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3692','Mumps virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human colon cancer cell line','HCT-116','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3693','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human cervix cancer cell line','HeLa','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3694','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human cervix cancer cell line','HeLa','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3695','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human cervix cancer cell line','SIHA','5000 cells per well','NA','MTT assay','1 MOI','50% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3696','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human cervix cancer cell line','SIHA','5000 cells per well','NA','MTT assay','1 MOI','15% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3697','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human nasopharyngeal cell line','HK-1','5000 cells per well','NA','MTT assay','1 MOI','50% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3698','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human nasopharyngeal cell line','HK-1','5000 cells per well','NA','MTT assay','1 MOI','Complete cell death after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3699','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human nasopharyngeal cell line','HONE-1','5000 cells per well','NA','MTT assay','1 MOI','50% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3700','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human nasopharyngeal cell line','HONE-1','5000 cells per well','NA','MTT assay','1 MOI','Complete cell death after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3701','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human eosopahgeal cancer cell line','EC109','5000 cells per well','NA','MTT assay','1 MOI','75% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3702','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human eosopahgeal cancer cell line','EC109','5000 cells per well','NA','MTT assay','1 MOI','50% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3703','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human eosopahgeal cancer cell line','KYSE 70','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3704','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human eosopahgeal cancer cell line','KYSE 70','5000 cells per well','NA','MTT assay','1 MOI','30% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3705','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human colon cancer cell line','HT-29','5000 cells per well','NA','MTT assay','1 MOI','70% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3706','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human colon cancer cell line','HT-29','5000 cells per well','NA','MTT assay','1 MOI','Complete cell death after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3707','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human colon cancer cell line','HCT-116','5000 cells per well','NA','MTT assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3708','Measles and mumps virus','wild type','RNA','Paramyxoviridae','None','No','Measles virus in combination with mumps virus','No','ATCC','Human colon cancer cell line','HCT-116','5000 cells per well','NA','MTT assay','1 MOI','50% cell viability after day 6','No','No','NA','No response','NA','Virus in combination with induce apiptosis in cancer cell','NA','NA','29485292'),
  ('OV_3709','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human malignant melanoma cell line','FM-9','NA','NA','Live cell imaging system','1% virus concentration','84% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3710','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human muscle rhabdomyosarcoma cell line','RD','NA','NA','Live cell imaging system','1% virus concentration','94% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3711','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human lung cancer cell line','A549','NA','NA','Live cell imaging system','1% virus concentration','92% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3712','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human fibroblast cell line','HDFa','NA','NA','Live cell imaging system','1% virus concentration','87% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3713','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Pancreatic adenocarcinoma cell line','HPAF-II','NA','NA','Live cell imaging system','1% virus concentration','75% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3714','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human breast cancer cell line','MCF-7','NA','NA','Live cell imaging system','1% virus concentration','27% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3715','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human malignant melanoma cell line','SK-Mel-28','NA','NA','Live cell imaging system','1% virus concentration','100% cell death','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3716','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human malignant melanoma cell line','FM-9','NA','NA','Live cell imaging system','10% virus concentration','94% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3717','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human muscle rhabdomyosarcoma cell line','RD','NA','NA','Live cell imaging system','10% virus concentration','98% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3718','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human lung cancer cell line','A549','NA','NA','Live cell imaging system','10% virus concentration','91% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3719','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human fibroblast cell line','HDFa','NA','NA','Live cell imaging system','10% virus concentration','87% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3720','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human pancreatic adenocarcinoma cell line','HPAF-II','NA','NA','Live cell imaging system','10% virus concentration','100% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3721','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human breast cancer cell line','MCF-7','NA','NA','Live cell imaging system','10% virus concentration','24% cell viability','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3722','Enterovirus','ECHO-7 virus stain Rigvir','RNA','Picornaviridae','None','Yes','No','No','Public health england','Human malignant melanoma cell line','SK-Mel-28','NA','NA','Live cell imaging system','10% virus concentration','100% cell death','No','No','NA','No response','NA','NA','NA','NA','29581783'),
  ('OV_3723','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3','NA','NA','Absorbance measurements','0.1 MOI','15% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3724','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3M-Luc','NA','NA','Absorbance measurements','0.1 MOI','50% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3725','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','Du145','NA','NA','Absorbance measurements','0.1 MOI','1% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3726','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','LNCaP','NA','NA','Absorbance measurements','0.1 MOI','70% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3727','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','VCaP','NA','NA','Absorbance measurements','0.1 MOI','70% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3728','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','LAPC4','NA','NA','Absorbance measurements','0.1 MOI','30% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3729','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','TRAMP-C1','NA','NA','Absorbance measurements','0.1 MOI','5% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3730','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3','NA','NA','Absorbance measurements','10 MOI','15% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3731','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','PC-3M-Luc','NA','NA','Absorbance measurements','10 MOI','18% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3732','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','Du145','NA','NA','Absorbance measurements','10 MOI','3% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3733','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','LNCaP','NA','NA','Absorbance measurements','10 MOI','15% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3734','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','VCaP','NA','NA','Absorbance measurements','10 MOI','30% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3735','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','LAPC4','NA','NA','Absorbance measurements','10 MOI','10% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3736','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','TRAMP-C1','NA','NA','Absorbance measurements','10 MOI','5% cell viable','No','No','NA','No response','Virus induce apoptosis in cancer cell','NA','NA','NA','29696636'),
  ('OV_3737','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','Du145','NA','NA','NA','NA','NA','Balb/c-rag and gamma negative xenograft for Du145 (2.0E+6)','1.0E+7 pfu','NA','Complete regression in tumor after day 80','Intratumoral','NA','NA','NA','29696636'),
  ('OV_3738','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','22RV1','NA','NA','NA','NA','NA','Balb/c-rag and gamma negative xenograft for 22Rv1 (2.0E+6)','1.0E+7 pfu','NA','Regression in tumor volume to 0.4 cm after day 80','Intratumoral','NA','NA','NA','29696636'),
  ('OV_3739','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','22RV1','NA','NA','NA','NA','NA','Balb/c-rag and gamma negative xenograft for 22Rv1 (2.0E+6)','1.0E+7 pfu','NA','Complete regression in tumor after day 80','Intravenous','NA','NA','NA','29696636'),
  ('OV_3740','Vesicular stomatitis virus','VSV-GP','RNA','Rhabdoviridae','virus expressing GP protein','Yes','No','No','ATCC','Human prostate cancer cell line','VCaP','NA','NA','NA','NA','NA','Balb/c-rag and gamma negative xenograft for VCap (2.0E+6)','1.0E+7 pfu','NA','Regression in tumor volume to 0.3 cm after day 80','Intratumoral','NA','NA','NA','29696636'),
  ('OV_3741','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.0001 MOI','100% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3742','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.001 MOI','100% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3743','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.01 MOI','80% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3744','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','1 MOI','20% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3745','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','2 MOI','100% cell killing after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3746','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','3 MOI','100% cell killing after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3747','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','0.0001 MOI','100% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3748','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','0.001 MOI','100% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3749','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','0.01 MOI','90% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3750','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','1 MOI','10% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3751','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','2 MOI','100% cell killing after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3752','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','3 MOI','100% cell killing after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3753','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','0.0001 MOI','100% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3754','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','0.001 MOI','100% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3755','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','0.01 MOI','98% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3756','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','1 MOI','20% cell survival after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3757','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','2 MOI','100% cell killing after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3758','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','3 MOI','100% cell killing after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3759','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (1 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.1 MOI','70% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3760','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (1 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.5 MOI','50% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3761','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (5 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.1 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3762','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (5 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','PANC-1','5.0E+3 cells per well','NA','MTT assay','0.5 MOI','20% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3763','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (1 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','0.1 MOI','70% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3764','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (1 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','0.5 MOI','50% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3765','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (5 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','0.1 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3766','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (5 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','5.0E+3 cells per well','NA','MTT assay','0.5 MOI','30% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3767','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (1 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','0.1 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3768','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (1 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','0.5 MOI','50% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3769','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (5 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','0.1 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3770','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (5 micromolar)','No','Type culture collection of china','Human pancreatic cancer cell line','BxPC-3','5.0E+3 cells per well','NA','MTT assay','0.5 MOI','30% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3771','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','NA','NA','NA','NA','NA','Balb/c nude mice xenograft for SW1990','2.0E+7 pfu','NA','Significant reduction in tumor volume after 56 days','Intratumoral','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3772','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (50mg/kg)','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990','NA','NA','NA','NA','NA','Balb/c nude mice xenograft for SW1990','2.0E+7 pfu','NA','Significant reduction in tumor volume to below 500mm after 56 days','Intratumoral','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3773','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','Yes','No','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990/Gemcitabine resistant','NA','NA','NA','NA','NA','Balb/c nude mice xenograft for SW1990','2.0E+7 pfu','NA','Significant reduction in tumor volume after 56 days','Intratumoral','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3774','Vaccinia virus','vv-smac','DNA','Poxviridae','Insertion of smac and gpt gene in TK','No','Virus in combination with gemcitabine (50mg/kg)','No','Type culture collection of china','Human pancreatic cancer cell line','SW1990/Gemcitabine resistant','NA','NA','NA','NA','NA','Balb/c nude mice xenograft for SW1990','2.0E+7 pfu','NA','Significant reduction in tumor volume to below 300mm after 56 days','Intratumoral','Virus induce apoptosis in cancer cell','NA','NA','30365143'),
  ('OV_3775','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','30% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3776','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','38% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3777','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','44% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3778','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','55% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3779','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','58% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3780','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','58% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3781','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','62% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3782','Newcastle disease virus','NDVstrain 880','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','65% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3783','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','70% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3784','Newcastle disease virus','NDVstrain 329','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','70% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3785','Newcastle disease virus','NDVstrain 485','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','80% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3786','Newcastle disease virus','NDVstrain 718','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','82% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3787','Newcastle disease virus','NDVstrain 53','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','85% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3788','Newcastle disease virus','NDVstrain 52','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','85% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3789','Newcastle disease virus','NDVstrain 746','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','85% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3790','Newcastle disease virus','NDVstrain 12','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','85% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3791','Newcastle disease virus','NDVstrain 49','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','90% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3792','Newcastle disease virus','NDVstrain 753','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','90% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3793','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','95% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3794','Newcastle disease virus','NDVstrain 789','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','95% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3795','Newcastle disease virus','NDVstrain 27','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','95% cells viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3796','Newcastle disease virus','NDVstrain 48','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3797','Newcastle disease virus','NDVstrain 389','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3798','Newcastle disease virus','NDVstrain AD','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3799','Newcastle disease virus','NDVstrain 922','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3800','Newcastle disease virus','NDVstrain 945','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3801','Newcastle disease virus','NDVstrain 429','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3802','Newcastle disease virus','NDVstrain 339','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3803','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','18% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3804','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','22% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3805','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','23% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3806','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','23% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3807','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','25% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3808','Newcastle disease virus','NDVstrain 860','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','26% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3809','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','42% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3810','Newcastle disease virus','NDVstrain 769','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','45% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3811','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','45% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3812','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','60% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3813','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','60% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3814','Newcastle disease virus','NDVstrain AD','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','62% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3815','Newcastle disease virus','NDVstrain 429','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','65% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3816','Newcastle disease virus','NDVstrain 27','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','65% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3817','Newcastle disease virus','NDVstrain 718','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','65% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3818','Newcastle disease virus','NDVstrain 49','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','68% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3819','Newcastle disease virus','NDVstrain 52','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','68% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3820','Newcastle disease virus','NDVstrain 329','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','75% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3821','Newcastle disease virus','NDVstrain 12','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','75% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3822','Newcastle disease virus','NDVstrain 53','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','79% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3823','Newcastle disease virus','NDVstrain 746','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','79% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3824','Newcastle disease virus','NDVstrain 389','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','82% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3825','Newcastle disease virus','NDVstrain 339','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','85% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3826','Newcastle disease virus','NDVstrain 922','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','90% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3827','Newcastle disease virus','NDVstrain 945','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','95% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3828','Newcastle disease virus','NDVstrain 753','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3829','Newcastle disease virus','NDVstrain 48','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3830','Newcastle disease virus','NDVstrain 465','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3831','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','23% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3832','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','34% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3833','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','35% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3834','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','38% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3835','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','39% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3836','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','40% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3837','Newcastle disease virus','NDVstrain 860','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','40% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3838','Newcastle disease virus','NDVstrain 753','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','40% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3839','Newcastle disease virus','NDVstrain AD','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','42% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3840','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','42% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3841','Newcastle disease virus','NDVstrain 718','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','50% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3842','Newcastle disease virus','NDVstrain 922','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','50% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3843','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','58% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3844','Newcastle disease virus','NDVstrain 53','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','60% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3845','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','60% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3846','Newcastle disease virus','NDVstrain 27','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','61% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3847','Newcastle disease virus','NDVstrain 769','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','61% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3848','Newcastle disease virus','NDVstrain 12','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','70% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3849','Newcastle disease virus','NDVstrain 945','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','78% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3850','Newcastle disease virus','NDVstrain 49','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','80% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3851','Newcastle disease virus','NDVstrain 52','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','81% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3852','Newcastle disease virus','NDVstrain 746','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','90% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3853','Newcastle disease virus','NDVstrain 465','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','90% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3854','Newcastle disease virus','NDVstrain 429','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','90% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3855','Newcastle disease virus','NDVstrain 329','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','97% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3856','Newcastle disease virus','NDVstrain 339','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','98% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3857','Newcastle disease virus','NDVstrain 389','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','98% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3858','Newcastle disease virus','NDVstrain 48','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3859','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','67% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3860','Newcastle disease virus','NDVstrain 27','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','67% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3861','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','67% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3862','Newcastle disease virus','NDVstrain AD','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','70% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3863','Newcastle disease virus','NDVstrain 860','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','72% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3864','Newcastle disease virus','NDVstrain 753','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','74% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3865','Newcastle disease virus','NDVstrain 429','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','75% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3866','Newcastle disease virus','NDVstrain 718','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','82% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3867','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','84% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3868','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','84% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3869','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','84% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3870','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','86% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3871','Newcastle disease virus','NDVstrain 922','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','86% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3872','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','90% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3873','Newcastle disease virus','NDVstrain 49','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','90% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3874','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','92% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3875','Newcastle disease virus','NDVstrain 945','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','94% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3876','Newcastle disease virus','NDVstrain 52','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','94% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3877','Newcastle disease virus','NDVstrain 48','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','94% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3878','Newcastle disease virus','NDVstrain 329','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','99% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3879','Newcastle disease virus','NDVstrain 746','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','99% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3880','Newcastle disease virus','NDVstrain 53','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3881','Newcastle disease virus','NDVstrain 389','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3882','Newcastle disease virus','NDVstrain 12','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3883','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3884','Newcastle disease virus','NDVstrain 465','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3885','Newcastle disease virus','NDVstrain 769','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3886','Newcastle disease virus','NDVstrain 339','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','100% cell viability after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3887','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','63% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3888','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','60% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3889','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','58% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3890','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','69% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3891','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','55% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3892','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','43% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3893','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','75% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3894','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','67% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3895','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','58% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3896','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','64% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3897','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','59% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3898','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','54% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3899','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','57% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3900','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','41% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3901','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','37% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3902','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','37% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3903','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','32% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3904','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','29% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3905','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','68% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3906','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','65% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3907','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','62% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3908','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','42% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3909','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','23% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3910','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','22% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3911','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','67% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3912','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','64% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3913','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','59% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3914','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','29% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3915','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','24% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3916','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','24% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3917','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','25% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3918','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','21% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3919','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','22% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3920','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','32% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3921','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','24% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3922','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','21% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3923','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','56% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3924','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','51% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3925','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','58% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3926','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','51% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3927','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','52% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3928','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','47% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3929','Newcastle disease virus','NDVstrain 769','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','51% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3930','Newcastle disease virus','NDVstrain 769','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','47% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3931','Newcastle disease virus','NDVstrain 769','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','46% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3932','Newcastle disease virus','NDVstrain 860','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','28% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3933','Newcastle disease virus','NDVstrain 860','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','20% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3934','Newcastle disease virus','NDVstrain 860','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','25% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3935','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','19% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3936','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','17% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3937','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','17% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3938','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','61% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3939','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','61% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3940','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','41% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3941','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','49% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3942','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','36% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3943','Newcastle disease virus','NDVstrain 264','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','34% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3944','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','30% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3945','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','33% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3946','Newcastle disease virus','NDVstrain 320','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','34% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3947','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','51% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3948','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','47% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3949','Newcastle disease virus','NDVstrain 321','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','46% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3950','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','58% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3951','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','59% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3952','Newcastle disease virus','NDVstrain 373','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','57% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3953','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','34% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3954','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','45% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3955','Newcastle disease virus','NDVstrain 770','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','40% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3956','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','44% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3957','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','22% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3958','Newcastle disease virus','NDVstrain 852','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','22% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3959','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','40% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3960','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','38% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3961','Newcastle disease virus','NDVstrain 776','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','38% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3962','Newcastle disease virus','NDVstrain 769','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','53% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3963','Newcastle disease virus','NDVstrain 769','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','60% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3964','Newcastle disease virus','NDVstrain 769','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','62% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3965','Newcastle disease virus','NDVstrain 860','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','59% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3966','Newcastle disease virus','NDVstrain 860','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','49% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3967','Newcastle disease virus','NDVstrain 860','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','40% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3968','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','72 cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3969','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','70% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3970','Newcastle disease virus','NDVstrain 777','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','60% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3971','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','44% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3972','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','39% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3973','Newcastle disease virus','NDVstrain 14','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','39% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3974','Newcastle disease virus','NDVstrain 718','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','59% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3975','Newcastle disease virus','NDVstrain 718','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','55% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3976','Newcastle disease virus','NDVstrain 718','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','49% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3977','Newcastle disease virus','NDVstrain 465','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','69% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3978','Newcastle disease virus','NDVstrain 465','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','61% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3979','Newcastle disease virus','NDVstrain 465','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','59% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3980','Newcastle disease virus','NDVstrain 922','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','79% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3981','Newcastle disease virus','NDVstrain 922','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','65% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3982','Newcastle disease virus','NDVstrain 922','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','52% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3983','Newcastle disease virus','NDVstrain 27','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','75% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3984','Newcastle disease virus','NDVstrain 27','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','65% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3985','Newcastle disease virus','NDVstrain 27','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','61% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3986','Newcastle disease virus','NDVstrain AD','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','63% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3987','Newcastle disease virus','NDVstrain AD','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','49% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3988','Newcastle disease virus','NDVstrain AD','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','46% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3989','Newcastle disease virus','NDVstrain 753','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','50% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3990','Newcastle disease virus','NDVstrain 753','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','50% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3991','Newcastle disease virus','NDVstrain 753','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','45% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3992','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','62% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3993','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','60% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3994','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','58% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3995','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','42% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3996','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','24% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3997','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','22% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3998','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','50% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_3999','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','45% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4000','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','45% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4001','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','2 HAU','82% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4002','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','8 HAU','82% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4003','Newcastle disease virus','NDVwild 264','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','82% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4004','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','70% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4005','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','58% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4006','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','42% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4007','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','70% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4008','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','65% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4009','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','60% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4010','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','35% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4011','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','37% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4012','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','38% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4013','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','2 HAU','100% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4014','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','8 HAU','100% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4015','Newcastle disease virus','NDVwild 320','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','70% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4016','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','70% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4017','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','65% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4018','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','58% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4019','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','30% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4020','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','25% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4021','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','24% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4022','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','50% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4023','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','45% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4024','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','44% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4025','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','2 HAU','95% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4026','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','8 HAU','70% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4027','Newcastle disease virus','NDVwild 321','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','95% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4028','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','62% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4029','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','60% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4030','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','58% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4031','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','25% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4032','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','20% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4033','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','22% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4034','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','59% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4035','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','59% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4036','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','59% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4037','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','2 HAU','100% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4038','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','8 HAU','100% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4039','Newcastle disease virus','NDVwild 373','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','100% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4040','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','50% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4041','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','42% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4042','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','38% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4043','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','30% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4044','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','22% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4045','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','20% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4046','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','30% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4047','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','42% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4048','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','39% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4049','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','2 HAU','79% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4050','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','8 HAU','80% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4051','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','80% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4052','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','38% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4053','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','35% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4054','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','30% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4055','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','58% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4056','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','50% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4057','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','60% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4058','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','45% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4059','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','20% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4060','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','20% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4061','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','2 HAU','62% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4062','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','8 HAU','62% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4063','Newcastle disease virus','NDVwild 852','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','62% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4064','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','2 HAU','68% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4065','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','8 HAU','65% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4066','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','State centre for virology and biotechnology, Russia','Human colon carcinoma cell line','HCT-116','10000 cells per well','NA','MTT assay','16 HAU','62% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4067','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','2 HAU','50% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4068','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','8 HAU','50% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4069','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','Institute of clinical and experimental lymphology, Russia','Human epitheloid cervix carcinoma','HeLa','10000 cells per well','NA','MTT assay','16 HAU','45% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4070','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','2 HAU','40% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4071','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','8 HAU','38% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4072','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','10000 cells per well','NA','MTT assay','16 HAU','38% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4073','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','2 HAU','90% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4074','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','8 HAU','90% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4075','Newcastle disease virus','NDVwild 776','RNA','Paramyxoviridae','None','Yes','No','No','Russian academy of science, Russia','Human breast cancer adenocarcinoma cell line','MCF-7','10000 cells per well','NA','MTT assay','16 HAU','80% cell survival after 4th day','No','No','NA','No response','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4076','Newcastle disease virus','NDVwild 770','RNA','Paramyxoviridae','None','Yes','No','No','Research institute of fundamental and clinical immunology, Russia','Human non-small lung carcinoma cell line','A549','NA','NA','NA','NA','NA','SCID mice xenograft for A459 cell (3.5E+6)','16 HAU','NA','4.2 fold decrease in tumor size compared to control after 15th day','NA','Virus induces apoptosis, necrosis and autophagy in cancer cells','Induction of MARK signalling pathway','NA','29621357'),
  ('OV_4077','Herpes simplex virus','G207','DNA','Herpesviridae','Deletion mutant for gamma 34.5 gene and and lacZ insertion into Ul39 gene encodes for ICP6 gene','Yes','No','No','Duke university medical centre','NA','NA','NA','NA','NA','NA','NA','Nude mice xenograft for medulloblastoma cell line D425 (2.5E+5)','1.0E+7 pfu','NA','Increase the survival time of mice from 15 days to 25 days','Intratumoral','NA','Increased expression of CD133 and CD15','NA','26188016'),
  ('OV_4078','Herpes simplex virus','G207','DNA','Herpesviridae','Deletion mutant for gamma 34.5 gene and and lacZ insertion into Ul39 gene encodes for ICP6 gene','Yes','No','No','Duke university medical centre','NA','NA','NA','NA','NA','NA','NA','Nude mice xenograft for medulloblastoma cell line D341 (5.0E+5)','1.0E+7 pfu','NA','Increase the survival time of mice from 32 days to above 60 days','Intratumoral','NA','Increased expression of CD133 and CD15','NA','26188016'),
  ('OV_4079','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for gamma 34.5 gene','Yes','No','Virus expressing murine IL-12 gene','Duke university medical centre','NA','NA','NA','NA','NA','NA','NA','Nude mice xenograft for medulloblastoma cell line D425 (2.5E+5)','1.0E+7 pfu','NA','Increase the survival time of mice from 20 days to above 90 days','Intratumoral','NA','Increased expression of CD133 and CD15','NA','26188016'),
  ('OV_4080','Herpes simplex virus','M002','DNA','Herpesviridae','Deletion mutant for gamma 34.5 gene','Yes','No','Virus expressing murine IL-12 gene','Duke university medical centre','NA','NA','NA','NA','NA','NA','NA','Nude mice xenograft for medulloblastoma cell line D341 (5.0E+5)','1.0E+7 pfu','NA','Increase the survival time of mice from 30 days to above 60 days','Intratumoral','NA','Increased expression of CD133 and CD15','NA','26188016'),
  ('OV_4081','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Virus encoded with drosophila dNK gene','No','Virus in combination with drug BVDU(10mg/kg)','No','Shanghai cell collection','Human breast cell line','MCF-7','1.0E+4 cells per well','NA','MTT assay','1 MOI','Significant reduction in cell growth','No','No','NA','No response','NA','Virus induced apoptosis in cancer cell','NA','NA','26203222'),
  ('OV_4082','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Virus encoded with drosophila dNK gene','No','Virus in combination with drug DFDC(10mg/kg)','No','Shanghai cell collection','Human breast cell line','MCF-7','1.0E+4 cells per well','NA','MTT assay','1 MOI','Significant reduction in cell growth','No','No','NA','No response','NA','Virus induced apoptosis in cancer cell','NA','NA','26203222'),
  ('OV_4083','Adenovirus','Adenovirus ZD55','DNA','Adenoviridae','Virus encoded with drosophila dNK gene','No','Virus in combination with drug DFDC(10mg/kg)','No','Shanghai cell collection','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice xenograft for MCF7 (1.0E+7)','1.0E+9 pfu','NA','Virus and drug prolongs the mice survival and reduction in tumor volume to 1000mm compared to control 3000mm after 60 days','Intratumoral','Virus induced apoptosis in cancer cell','NA','NA','26203222'),
  ('OV_4084','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of veterinary medicine, germany','Human mammary carcinoma cell line','MTH52c','NA','NA','MTT assay','0.1 MOI','90% cell survival after 24 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4085','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of veterinary medicine, germany','Human mammary adenoma cell line','ZMTH3','NA','NA','MTT assay','0.1 MOI','90% cell survival after 24 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4086','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of veterinary medicine, germany','Human prostate carcinoma cell line','CT1258','NA','NA','MTT assay','0.1 MOI','90% cell survival after 24 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4087','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of colorado, USA','Human canine soft tissue sarcoma','STSA-1','NA','NA','MTT assay','0.1 MOI','100% cell survival after 24 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4088','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of veterinary medicine, germany','Human mammary carcinoma cell line','MTH52c','NA','NA','MTT assay','0.1 MOI','50% cell survival after 48 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4089','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of veterinary medicine, germany','Human mammary adenoma cell line','ZMTH3','NA','NA','MTT assay','0.1 MOI','30% cell survival after 48 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4090','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of veterinary medicine, germany','Human prostate carcinoma cell line','CT1258','NA','NA','MTT assay','0.1 MOI','40% cell survival after 48 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4091','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of colorado, USA','Human canine soft tissue sarcoma','STSA-1','NA','NA','MTT assay','0.1 MOI','60% cell survival after 48 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4092','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of veterinary medicine, germany','Human mammary carcinoma cell line','MTH52c','NA','NA','MTT assay','0.1 MOI','25% cell survival after 72 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4093','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of veterinary medicine, germany','Human mammary adenoma cell line','ZMTH3','NA','NA','MTT assay','0.1 MOI','10% cell survival after 72 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4094','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of veterinary medicine, germany','Human prostate carcinoma cell line','CT1258','NA','NA','MTT assay','0.1 MOI','10% cell survival after 72 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4095','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of colorado, USA','Human canine soft tissue sarcoma','STSA-1','NA','NA','MTT assay','0.1 MOI','40% cell survival after 72 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4096','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of veterinary medicine, germany','Human mammary carcinoma cell line','MTH52c','NA','NA','MTT assay','0.1 MOI','95% cell survival after 24 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4097','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of veterinary medicine, germany','Human mammary adenoma cell line','ZMTH3','NA','NA','MTT assay','0.1 MOI','95% cell survival after 24 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4098','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of veterinary medicine, germany','Human prostate carcinoma cell line','CT1258','NA','NA','MTT assay','0.1 MOI','95% cell survival after 24 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4099','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of colorado, USA','Human canine soft tissue sarcoma','STSA-1','NA','NA','MTT assay','0.1 MOI','95% cell survival after 24 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4100','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of veterinary medicine, germany','Human mammary carcinoma cell line','MTH52c','NA','NA','MTT assay','0.1 MOI','60% cell survival after 48 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4101','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of veterinary medicine, germany','Human mammary adenoma cell line','ZMTH3','NA','NA','MTT assay','0.1 MOI','30% cell survival after 48 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4102','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of veterinary medicine, germany','Human prostate carcinoma cell line','CT1258','NA','NA','MTT assay','0.1 MOI','50% cell survival after 48 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4103','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of colorado, USA','Human canine soft tissue sarcoma','STSA-1','NA','NA','MTT assay','0.1 MOI','60% cell survival after 48 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4104','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of veterinary medicine, germany','Human mammary carcinoma cell line','MTH52c','NA','NA','MTT assay','0.1 MOI','20% cell survival after 72 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4105','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of veterinary medicine, germany','Human mammary adenoma cell line','ZMTH3','NA','NA','MTT assay','0.1 MOI','25% cell survival after 72 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4106','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of veterinary medicine, germany','Human prostate carcinoma cell line','CT1258','NA','NA','MTT assay','0.1 MOI','10% cell survival after 72 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4107','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of colorado, USA','Human canine soft tissue sarcoma','STSA-1','NA','NA','MTT assay','0.1 MOI','50% cell survival after 72 hours','No','No','NA','No response','NA','NA','NA','NA','26205404'),
  ('OV_4108','Vaccinia virus','VVstrain LIVP 6.1.1','DNA','Poxviridae','Mutant for J2R gene','Yes','No','No','University of colorado, USA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for STSA-1 cell line (1.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to 1000 mm compared to control 2500mm after 42 days','Intravenous','NA','NA','NA','26205404'),
  ('OV_4109','Vaccinia virus','VVstrain GLV-5b451','DNA','Poxviridae','Derived from LIVP6.1.1 by inserting glaf-2 gene into J2R locus','Yes','No','No','University of colorado, USA','NA','NA','NA','NA','NA','NA','NA','Hsd athymic nude mice xenograft for STSA-1 cell line (1.0E+6)','1.0E+7 pfu','NA','Tumor volume reduced to 200 mm compared to control 2500mm after 49 days','Intravenous','NA','NA','NA','26205404'),
  ('OV_4110','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human colon carcinoma cell line','Caco-2','1.0E+5 cells per well','NA','MTT assay','0.1 MOI','80% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4111','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human lung cancer cell line','A549','1.0E+5 cells per well','NA','MTT assay','0.1 MOI','90% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4112','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human osteosarcoma cell line','U2OS','1.0E+5 cells per well','NA','MTT assay','0.1 MOI','95% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4113','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human fibroblast cell line BJ','BJ','1.0E+5 cells per well','NA','MTT assay','0.1 MOI','95% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4114','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human colon carcinoma cell line','Caco-2','1.0E+5 cells per well','NA','MTT assay','1 MOI','40% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4115','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human lung cancer cell line','Caco-2','1.0E+5 cells per well','NA','MTT assay','1 MOI','50% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4116','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human osteosarcoma cell line','U2OS','1.0E+5 cells per well','NA','MTT assay','1 MOI','90% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4117','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human fibroblast cell line','BJ','1.0E+5 cells per well','NA','MTT assay','1 MOI','95% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4118','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human colon carcinoma cell line','Caco-2','1.0E+5 cells per well','NA','MTT assay','10 MOI','10% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4119','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human lung cancer cell line','Caco-2','1.0E+5 cells per well','NA','MTT assay','10 MOI','20% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4120','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human osteosarcoma cell line','U2OS','1.0E+5 cells per well','NA','MTT assay','10 MOI','90% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4121','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human fibroblast cell line','BJ','1.0E+5 cells per well','NA','MTT assay','10 MOI','90% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4122','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human colon carcinoma cell line','Caco-2','1.0E+5 cells per well','NA','MTT assay','100 MOI','5% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4123','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human lung cancer cell line','Caco-2','1.0E+5 cells per well','NA','MTT assay','100 MOI','30% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4124','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human osteosarcoma cell line','U2OS','1.0E+5 cells per well','NA','MTT assay','100 MOI','95% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4125','Adenovirus','Ad-CCL20-CD40L','DNA','Adenoviridae','Addition of CCL20 and CD40L gene near by TERT promoter','Yes','No','virus expressing CCL20 chemokine gene','ATCC','Human fibroblast cell line','BJ','1.0E+5 cells per well','NA','MTT assay','100 MOI','95% cell survival after 7 days','No','No','NA','No response','NA','NA','NA','NA','26208317'),
  ('OV_4126','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (0.01 ng/ml)','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','100 vp/cell','80% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4127','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (1 ng/ml)','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','1000 vp/cell','50% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4128','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (10 ng/ml)','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','10000 vp/cell','20% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4129','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (100 ng/ml)','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','100000 vp/cell','100% cell killing','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4130','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (1000 ng/ml)','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','1000000 vp/cell','100% cell killing','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4131','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','100 vp/cell','100% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4132','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','1000 vp/cell','85% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4133','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','10000 vp/cell','35% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4134','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','100000 vp/cell','20% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4135','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','BxPC-3','3.0E+3 cells per well','NA','MTT assay','1000000 vp/cell','100% cell killing','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4136','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (1000 ng/ml)','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','1 vp/cell','100% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4137','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (10000 ng/ml)','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','10 vp/cell','100% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4138','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (100000 ng/ml)','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','100 vp/cell','70% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4139','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (1000000 ng/ml)','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','1000 vp/cell','20% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4140','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (10000000 ng/ml)','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','10000 vp/cell','100% cancer cell killing','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4141','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with drug Gemcitabine (100000000 ng/ml)','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','100000 vp/cell','100% cancer cell killing','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4142','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','1 vp/cell','100% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4143','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','10 vp/cell','100% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4144','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','100 vp/cell','100% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4145','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','1000 vp/cell','40% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4146','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','10000 vp/cell','10% cell survival','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4147','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','Yes','No','No','ATCC','Human pancreatic cancer cell line','PANC-1','3.0E+3 cells per well','NA','MTT assay','100000 vp/cell','100% cancer cell killing','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4148','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with gemcitabine (160mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for BxPC-3 (5.0E+5)','5.0E+10 VP per cell','NA','Median survival time increased from 22 days to 57 days with combined tretament','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4149','Adenovirus','AduPARE1A','DNA','Adenoviridae','Addition of E1A gene upstream of uPAR promoter','No','Virus in combination with gemcitabine (160mg/kg)','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for PANC-1 (5.0E+5)','5.0E+10 VP per cell','NA','Median survival time increased from 37 days to 79.5 days with combined tretament','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26227809'),
  ('OV_4150','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4151','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4152','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','60% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4153','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','25% cell viability after 6 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4154','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','10% cell viability after 7 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4155','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4156','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','40% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4157','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','30% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4158','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','10% cell viability after 6 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4159','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','100% cell killing after 7 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4160','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4161','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','60% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4162','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','50% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4163','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','5% cell viability after 6 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4164','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','0.1 MOI','100% cell killing after 7 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4165','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4166','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','20% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4167','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','15% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4168','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','2% cell viability after 6 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4169','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MCF-7','5000 cells per well','NA','MTT assay','1 MOI','100% cell killing after 7 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4170','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4171','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','90% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4172','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4173','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','40% cell viability after 6 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4174','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','30% cell viability after 7 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4175','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4176','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','50% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4177','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','20% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4178','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','10% cell viability after 6 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4179','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','Yes','No','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','10% cell viability after 7 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4180','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4181','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','80% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4182','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','58% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4183','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','20% cell viability after 6 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4184','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 2 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','0.1 MOI','100% cell killing after 7 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4185','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','100% cell viability after 24 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4186','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','50% cell viability after 48 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4187','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','10% cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4188','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','100% cell killing after 6 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4189','Measles virus','MV-s-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing H.pylori neutophil activating protein','No','Virus in combination with Alisertib (70nM) before 48 hours of MV infection','No','ATCC','Human breast cancer cell line','MDA 231-lu-PA','5000 cells per well','NA','MTT assay','1 MOI','100% cell killing after 7 days','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4190','Measles virus','MV-lambda-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing human lambda immunoglobulin chain','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Female athymic nude mice xenograft for MDA-231-lu-P4 (1.0E+6 cells)','2.0E+6 TCID50','NA','All mice dead after 100 days','Intravenous','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4191','Measles virus','MV-lambda-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing human lambda immunoglobulin chain','No','Virus in combination with Alisertib 30mg/kg for 3 weeks','No','NA','NA','NA','NA','NA','NA','NA','NA','Female athymic nude mice xenograft for MDA-231-lu-P4 (1.0E+6 cells)','2.0E+6 TCID50','NA','Mice median survival time increased to 82.5 days compared to control','Intravenous','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4192','Measles virus','MV-lambda-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing human lambda immunoglobulin chain','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Female athymic nude mice xenograft for MDA-231-lu-P4 (2.0E+6), pleural effusion transthoracic cavity','5.0E+5 TCID50','NA','Mice median survival increased to 57 days','Transthoracic','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4193','Measles virus','MV-lambda-NAP','RNA','Paramyxoviridae','Genetically engineered for expressing human lambda immunoglobulin chain','Yes','Virus in combination with Alisertib 30mg/kg for 3 weeks','No','NA','NA','NA','NA','NA','NA','NA','NA','Female athymic nude mice xenograft for MDA-231-lu-P4 (2.0E+6), pleural effusion transthoracic cavity','5.0E+5 TCID50','NA','Mice median survival increased to 74 days compared to control 57 days','Transthoracic','Virus induce apoptosis process leads to cancer cell death','Virus and drug both cause induction of IL-24 expression','In clinical trials','26272026'),
  ('OV_4194','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','100% cell viability after day 1','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4195','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','100% cell viability after day 2','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4196','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','100% cell viability after day 3','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4197','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','100% cell viability after day 4','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4198','Adenovirus','wild type','DNA','Adenoviridae','None','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','100% cell viability after day 5','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4199','Adenovirus','Ad-CXCR4-DAL1','DNA','Adenoviridae','Virus expressing DAL-1 gene under promoter CXXR4','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','100% cell viability after day 1','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4200','Adenovirus','Ad-CXCR4-DAL1','DNA','Adenoviridae','Virus expressing DAL-1 gene under promoter CXXR4','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','100% cell viability after day 2','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4201','Adenovirus','Ad-CXCR4-DAL1','DNA','Adenoviridae','Virus expressing DAL-1 gene under promoter CXXR4','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','100% cell viability after day 3','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4202','Adenovirus','Ad-CXCR4-DAL1','DNA','Adenoviridae','Virus expressing DAL-1 gene under promoter CXXR4','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','100% cell viability after day 4','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4203','Adenovirus','Ad-CXCR4-DAL1','DNA','Adenoviridae','Virus expressing DAL-1 gene under promoter CXXR4','Yes','No','No','Cell bank of chinese academy of science','Human lung adenocarcinoma cell line','A549','1.0E+6 cells per well','NA','CCK-8 assay','100 MOI','10% cell viability after day 5','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4204','Adenovirus','Ad-CXCR4-DAL1','DNA','Adenoviridae','Virus expressing DAL-1 gene under promoter CXXR4','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice subcutaneously xenograft for A549 cell (2.0E+6)','1.0E+9 pfu, every other day for 3 times','NA','Reduction in tumor volume to 1.5 centimeter cube after 28 days compared to control 7 centimeter cube','Intratumoral','Virus induce apoptosis process leads to cancer cell death','NA','NA','26280082'),
  ('OV_4205','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','SK-N-SH','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','1 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4206','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','IMR-32','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','3 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4207','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','GOTO','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','5 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4208','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Dr. R.C. Seeger, LA','Human neuroblastoma cell line','Lan-5','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','8 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Maximum increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4209','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Dr. T. Sugimoto, Japan','Human neuroblastoma cell line','RT-BM-1','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','8 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4210','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','SK-N-SH','1.0E+5 cells per well','NA','Luminiscence measurement','0.01 MOI','1 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4211','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','SK-N-SH','1.0E+5 cells per well','NA','Luminiscence measurement','0.1 MOI','1 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4212','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','SK-N-SH','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','1 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4213','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','IMR-32','1.0E+5 cells per well','NA','Luminiscence measurement','0.01 MOI','2 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4214','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','IMR-32','1.0E+5 cells per well','NA','Luminiscence measurement','0.1 MOI','2 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4215','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','IMR-32','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','2 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4216','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Dr. R.C. Seeger, LA','Human neuroblastoma cell line','Lan-5','1.0E+5 cells per well','NA','Luminiscence measurement','0.01 MOI','10 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Maximum increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4217','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Dr. R.C. Seeger, LA','Human neuroblastoma cell line','Lan-5','1.0E+5 cells per well','NA','Luminiscence measurement','0.1 MOI','7 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Maximum increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4218','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Dr. R.C. Seeger, LA','Human neuroblastoma cell line','Lan-5','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','6 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Maximum increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4219','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','GOTO','1.0E+5 cells per well','NA','Luminiscence measurement','0.01 MOI','2 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4220','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','GOTO','1.0E+5 cells per well','NA','Luminiscence measurement','0.1 MOI','2 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4221','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Japanese cancer research resource bank','Human neuroblastoma cell line','GOTO','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','2 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4222','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Dr. T. Sugimoto, Japan','Human neuroblastoma cell line','RT-BM-1','1.0E+5 cells per well','NA','Luminiscence measurement','0.01 MOI','20 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4223','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Dr. T. Sugimoto, Japan','Human neuroblastoma cell line','RT-BM-1','1.0E+5 cells per well','NA','Luminiscence measurement','0.1 MOI','10 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4224','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','Dr. T. Sugimoto, Japan','Human neuroblastoma cell line','RT-BM-1','1.0E+5 cells per well','NA','Luminiscence measurement','1 MOI','5 % cell viability after 72 hours','No','No','NA','No response','NA','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4225','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 21 days in mice 1 and increase in PFS above 200 days compared to control 75 days','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4226','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 42 days in mice 2 and increase in PFS above 200 days compared to control 75 days','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4227','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 49 days in mice 3 and increase in PFS above 200 days compared to control 75 days','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4228','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 56 days in mice 4 and increase in PFS above 200 days compared to control 75 days','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4229','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)','1.0E+6 pfu','NA','Reduction in tumor volume to 100 cubic millimetet after 70 days in mice 1 and increase in PFS above 200 days from 150 days to control','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4230','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 49 days in mice 2 and increase in PFS above 200 days from 150 days to control','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4231','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 49 days in mice 3 and increase in PFS above 200 days from 150 days to control','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4232','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 56 days in mice 4 and increase in PFS above 200 days from 150 days to control','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4233','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 56 days in mice 5 and increase in PFS above 200 days from 150 days to control','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4234','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for IMR-32 (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 70 days in mice 6 and increase in PFS above 200 days from 150 days to control','Intratumoral','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4235','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Reduction in tumor volume to 1000 cubic millimeter in mice 1 after 56 days','Intravenous','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4236','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 28 days in mice 2','Intravenous','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4237','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 28 days in mice 3','Intravenous','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4238','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 28 days in mice 4','Intravenous','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4239','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 48 days in mice 5','Intravenous','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4240','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 56 days in mice 6','Intravenous','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4241','Sindbis virus','AR339','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c AnNcrj-nu/nu female mice xenograft for SK-N-SH (1.0E+6)','1.0E+6 pfu','NA','Complete reduction in tumor volume after 56 days in mice 7','Intravenous','Virus induce apoptosis process leads to cancer cell death','Increased expression of Bcl-2 and Bcl-xL expression','NA','26298056'),
  ('OV_4242','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','ABC-1','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 1','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4243','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','ABC-1','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4244','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','ABC-1','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','60% cell viability after day 5','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4245','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','ABC-1','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','45% cell viability after day 7','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4246','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','National institute of biomedical innovation, Japan','Human nonsmall cell lung carcinoma cell line','NCI-H441','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 1','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4247','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','National institute of biomedical innovation, Japan','Human nonsmall cell lung carcinoma cell line','NCI-H441','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4248','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','National institute of biomedical innovation, Japan','Human nonsmall cell lung carcinoma cell line','NCI-H441','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','35% cell viability after day 5','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4249','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','National institute of biomedical innovation, Japan','Human nonsmall cell lung carcinoma cell line','NCI-H441','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell killing after day 7','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4250','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H2170','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','90% cell viability after day 1','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4251','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H2170','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','38% cell viability after day 3','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4252','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H2170','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','20% cell viability after day 5','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4253','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H2170','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell killing after day 7','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4254','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H358','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 1','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4255','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H358','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','55% cell viability after day 3','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4256','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H358','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','30% cell viability after day 5','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4257','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H358','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','20% cell viability after day 7','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4258','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','Calu-3','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 1','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4259','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','Calu-3','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','80% cell viability after day 3','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4260','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','Calu-3','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','42% cell viability after day 5','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4261','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','Calu-3','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','30% cell viability after day 7','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4262','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H1666','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 1','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4263','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H1666','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','60% cell viability after day 3','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4264','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H1666','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','40% cell viability after day 5','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4265','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','ATCC','Human nonsmall cell lung carcinoma cell line','NCI-H1666','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','25% cell viability after day 7','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4266','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','PC-14','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 1','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4267','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','PC-14','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 3','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4268','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','PC-14','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 5','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4269','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','PC-14','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','80% cell viability after day 7','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4270','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','A431','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 1','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4271','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','A431','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 3','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4272','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','A431','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','100% cell viability after day 5','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4273','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','Human nonsmall cell lung carcinoma cell line','A431','5.0E+3 cells per well','NA','WST-1 assay','1 MOI','80% cell viability after day 7','No','No','NA','No response','NA','NA','NA','NA','26317644'),
  ('OV_4274','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for NCI-H441 cell (5.0E+6)','1.0E+6 TCID50','NA','Reduction in tumor volume 500 cubic millimeter after 40 days compared to control 2500 cubic millimeter','Intratumoral','NA','NA','NA','26317644'),
  ('OV_4275','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human melanoma cell line','B16','4000 cells per well','NA','MTT assay','10 pfu','2.19 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4276','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma cell line','Hep3B','4000 cells per well','NA','MTT assay','10 pfu','3.8 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4277','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal adenocarcinoma cell line','LoVo','4000 cells per well','NA','MTT assay','10 pfu','6.9 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4278','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human bladder squamous cell carcinoma cell line','SCaBER','4000 cells per well','NA','MTT assay','10 pfu','11.5 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4279','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human cervix carcinoma','C33A','4000 cells per well','NA','MTT assay','10 pfu','14.8 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4280','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human bladder transitional cell carcinoma','T24','4000 cells per well','NA','MTT assay','10 pfu','21.1 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4281','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human nasopharyngeal carcinoma','CNE-2','4000 cells per well','NA','MTT assay','10 pfu','24.5 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4282','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human breast carcinoma','4T1','4000 cells per well','NA','MTT assay','10 pfu','26.27 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4283','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human glioblastoma','C6','4000 cells per well','NA','MTT assay','10 pfu','31.4 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4284','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human glioblastoma','U-87 MG','4000 cells per well','NA','MTT assay','10 pfu','32.4 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4285','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human glioblastoma','U251','4000 cells per well','NA','MTT assay','10 pfu','34.7 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4286','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal adenocarcinoma','HCT-8','4000 cells per well','NA','MTT assay','10 pfu','35.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4287','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human glioblastoma multiforme','T98G','4000 cells per well','NA','MTT assay','10 pfu','38.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4288','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human prostate carcinoma','22Rv1','4000 cells per well','NA','MTT assay','10 pfu','39.1 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4289','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human bladder transitional cell carcinoma','UM-UC-3','4000 cells per well','NA','MTT assay','10 pfu','39.8 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4290','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human glioblastoma','U-138 MG','4000 cells per well','NA','MTT assay','10 pfu','40.1 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4291','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal adenocarcinoma','SW620','4000 cells per well','NA','MTT assay','10 pfu','43.7 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4292','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human breast carcinoma','MDA-MB-468','4000 cells per well','NA','MTT assay','10 pfu','43.7 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4293','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreas epithelioid carcinoma','SW1990','4000 cells per well','NA','MTT assay','10 pfu','45.6 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4294','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human skin malignant melanoma','A375','4000 cells per well','NA','MTT assay','10 pfu','47.3 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4295','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human nasopharyngeal carcinoma','CNE-1','4000 cells per well','NA','MTT assay','10 pfu','48.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4296','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreas carcinoma','MIAPaCa-2','4000 cells per well','NA','MTT assay','10 pfu','49.1 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4297','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreas epithelioid carcinoma','PANC-1','4000 cells per well','NA','MTT assay','10 pfu','49.3 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4298','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human bladder carcinoma','5637','4000 cells per well','NA','MTT assay','10 pfu','50.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4299','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma','Huh-7','4000 cells per well','NA','MTT assay','10 pfu','52.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4300','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal adenocarcinoma','SW480','4000 cells per well','NA','MTT assay','10 pfu','53.8 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4301','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human breast adenocarcinoma','MDA-MB-231','4000 cells per well','NA','MTT assay','10 pfu','58.9 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4302','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human hepatoblastoma','Huh-6','4000 cells per well','NA','MTT assay','10 pfu','59 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4303','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human glioma','MGR2','4000 cells per well','NA','MTT assay','10 pfu','63.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4304','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human cervix adenocarcinoma','HeLa','4000 cells per well','NA','MTT assay','10 pfu','66 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4305','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human lung carcinoma','A549','4000 cells per well','NA','MTT assay','10 pfu','68.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4306','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human liver adenocarcinoma','SK-HEP-1','4000 cells per well','NA','MTT assay','10 pfu','71.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4307','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human hepatoma','Li-7','4000 cells per well','NA','MTT assay','10 pfu','72.1 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4308','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human prostate adenocarcinoma','PC-3','4000 cells per well','NA','MTT assay','10 pfu','72.7 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4309','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human gastric carcinoma','NCI-N87','4000 cells per well','NA','MTT assay','10 pfu','76.4 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4310','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human nasopharyngeal carcinoma','HNE-1','4000 cells per well','NA','MTT assay','10 pfu','76.5 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4311','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human gastric carcinoma','HGC-27','4000 cells per well','NA','MTT assay','10 pfu','79.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4312','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human hepatoma','PLC','4000 cells per well','NA','MTT assay','10 pfu','80.5 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4313','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','10 pfu','81.3 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4314','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human glioblastoma','DBTRG-05MG','4000 cells per well','NA','MTT assay','10 pfu','83.3 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4315','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreas adenocarcinoma','Capan-1','4000 cells per well','NA','MTT assay','10 pfu','85.1 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4316','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human acute promyelocytic leukemia','HL-60','4000 cells per well','NA','MTT assay','10 pfu','85.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4317','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human mammary ductal carcinoma','T-47D','4000 cells per well','NA','MTT assay','10 pfu','86.5 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4318','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human nonsmall cell lung cancer','NCI-H358','4000 cells per well','NA','MTT assay','10 pfu','87.8 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4319','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human hepatocellular carcinoma','HepG2','4000 cells per well','NA','MTT assay','10 pfu','88.6 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4320','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human breast adenocarcinoma','SK-BR-3','4000 cells per well','NA','MTT assay','10 pfu','89.6 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4321','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human prostate carcinoma','Du145','4000 cells per well','NA','MTT assay','10 pfu','91.4 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4322','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human gastric adenocarcinoma','AGS','4000 cells per well','NA','MTT assay','10 pfu','92.3 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4323','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human glioblastoma','LN-18','4000 cells per well','NA','MTT assay','10 pfu','92.5 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4324','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human breast adenocarcinoma','MCF-7','4000 cells per well','NA','MTT assay','10 pfu','95.2 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4325','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','SICB','Human bladder transitional cell carcinoma','EJ','4000 cells per well','NA','MTT assay','10 pfu','95.3 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4326','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human nonsmall cell lung cancer','H-1299','4000 cells per well','NA','MTT assay','10 pfu','96.3 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4327','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human bladder transitional cell carcinoma','J82','4000 cells per well','NA','MTT assay','10 pfu','96.8 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4328','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human glioblastoma','LN-229','4000 cells per well','NA','MTT assay','10 pfu','98.6 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4329','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human glioblastoma','A-172','4000 cells per well','NA','MTT assay','10 pfu','98.7 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4330','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreas adenocarcinoma','BxPC-3','4000 cells per well','NA','MTT assay','10 pfu','98.8 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4331','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human large cell lung cancer','NCI-H460','4000 cells per well','NA','MTT assay','10 pfu','99.5 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4332','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human cervix squamous cell carcinoma','SiHa','4000 cells per well','NA','MTT assay','10 pfu','99.6 % cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4333','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human urinary bladder cancer cell line','T24','4000 cells per well','NA','MTT assay','0.001 MOI','90% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4334','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human urinary bladder cancer cell line','T24','4000 cells per well','NA','MTT assay','0.01 MOI','80% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4335','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human urinary bladder cancer cell line','T24','4000 cells per well','NA','MTT assay','0.1 MOI','50% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4336','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human urinary bladder cancer cell line','T24','4000 cells per well','NA','MTT assay','10 MOI','38% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4337','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human urinary bladder cancer cell line','T24','4000 cells per well','NA','MTT assay','100 MOI','30% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4338','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human hepatoblastoma','Huh-6','4000 cells per well','NA','MTT assay','0.001 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4339','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human hepatoblastoma','Huh-6','4000 cells per well','NA','MTT assay','0.01 MOI','98% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4340','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human hepatoblastoma','Huh-6','4000 cells per well','NA','MTT assay','0.1 MOI','90% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4341','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human hepatoblastoma','Huh-6','4000 cells per well','NA','MTT assay','10 MOI','78% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4342','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human hepatoblastoma','Huh-6','4000 cells per well','NA','MTT assay','100 MOI','62% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4343','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','0.001 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4344','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','0.01 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4345','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4346','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','10 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4347','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','100 MOI','90% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4348','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','0.001 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4349','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','0.01 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4350','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4351','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','10 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4352','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','100 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4353','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreatic adenocarcinoma cell line','Capan-1','4000 cells per well','NA','MTT assay','0.001 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4354','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreatic adenocarcinoma cell line','Capan-1','4000 cells per well','NA','MTT assay','0.01 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4355','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreatic adenocarcinoma cell line','Capan-1','4000 cells per well','NA','MTT assay','0.1 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4356','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreatic adenocarcinoma cell line','Capan-1','4000 cells per well','NA','MTT assay','10 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4357','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','ATCC','Human pancreatic adenocarcinoma cell line','Capan-1','4000 cells per well','NA','MTT assay','100 MOI','100% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4358','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with dbcAMP 100 micromoalr','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','0.001 MOI','40% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4359','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with dbcAMP 200 micromoalr','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','0.01 MOI','30% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4360','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with dbcAMP 400 micromoalr','No','ATCC','Human colorectal carcinoma','HCT-116','4000 cells per well','NA','MTT assay','0.1 MOI','30% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4361','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with dbcAMP 100 micromoalr','No','ATCC','Human pancreatic adenocarcinoma cell line','Capan-1','4000 cells per well','NA','MTT assay','0.001 MOI','70% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4362','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with dbcAMP 200 micromoalr','No','ATCC','Human pancreatic adenocarcinoma cell line','Capan-1','4000 cells per well','NA','MTT assay','0.01 MOI','60% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4363','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with dbcAMP 400 micromoalr','No','ATCC','Human pancreatic adenocarcinoma cell line','Capan-1','4000 cells per well','NA','MTT assay','0.1 MOI','30% cell viability after 72 hours','No','No','NA','No response','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4364','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with 8-CPT-cAMP (20mg/kg/day)','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice subcutaneous xenograft for HCT-116 (5.0E+6)','3.0E+7 pfu','NA','Reduction in tumor volume to below 0.4 cubic centimeter after 22 days compared to control 1.2 cubic centimeter','Intravenous','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4365','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with 8-CPT-cAMP (20mg/kg/day)','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice subcutaneous xenograft for Hep3B (5.0E+6)','5.0E+6 pfu','NA','Reduction in tumor volume to below 1.5 cubic centimeter after 22 days compared to control 7.5 cubic centimeter','Intravenous','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4366','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with 8-CPT-cAMP (20mg/kg/day)','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c nude mice subcutaneous xenograft for Capan-1 (1.0E+7)','3.0E+7 pfu','NA','Reduction in tumor volume to below 0.2 cubic centimeter after 22 days compared to control 0.8 cubic centimeter','Intravenous','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4367','Alphavirus','M1','RNA','Togaviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Human liver cancer explant','5.0E+7 pfu','Slightly toxic to cancer cell','10.8% cancer cell growth inhibition','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4368','Alphavirus','M1','RNA','Togaviridae','None','No','Virus in combination with 8-CPT-cAMP (1 mmol/l)','No','NA','NA','NA','NA','NA','NA','NA','NA','Human liver cancer explant','5.0E+7 pfu','Slightly toxic to cancer cell','47% cancer cell growth inhibition','NA','Activation of cAMP signalling leads to induced expression of antiviral factors, severe ER stress and cell apoptosis','NA','NA','26373347'),
  ('OV_4369','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human skin metastasis','SK-MEL-2','2000 cells per well','NA','Luciferase based ATP assay','0.013 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4370','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human axillary node metastasis','SKMEL-5','1000 cells per well','NA','Luciferase based ATP assay','0.017 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4371','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human filamin-1 transfected M2 skin melanoma cell line','A7','500 cells per well','NA','Luciferase based ATP assay','0.020 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4372','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human lung metastasis cell line','MALME-3M','1000 cells per well','NA','Luciferase based ATP assay','0.038 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4373','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human malignant melanoma cell line','UACC-257','1000 cells per well','NA','Luciferase based ATP assay','0.083 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4374','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human malignant melanoma cell line','SK-MEL-28','500 cells per well','NA','Luciferase based ATP assay','0.257 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4375','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lymph node metastasis cell line','SKMEL-3','1000 cells per well','NA','Luciferase based ATP assay','0.286 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4376','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human bowes melanoma cell line','HMCB','750 cells per well','NA','Luciferase based ATP assay','0.310 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4377','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human lymph node metastasis cell line','LOX-IMVI','1000 cells per well','NA','Luciferase based ATP assay','0.788 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4378','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human malignant melanoma cell line','UCSD-24L','500 cells per well','NA','Luciferase based ATP assay','0.798 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4379','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human primary melanoma cell line','A375','250 cells per well','NA','Luciferase based ATP assay','0.948 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4380','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human malignant melanoma cell line','UACC-62','500 cells per well','NA','Luciferase based ATP assay','1 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4381','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lymph node metastasis cell line','RPMI-7951','500 cells per well','NA','Luciferase based ATP assay','2.565 MOI','50% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4382','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human skin metastasis','SK-MEL-2','2000 cells per well','NA','Luciferase based ATP assay','0.058 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4383','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human axillary node metastasis','SKMEL-5','1000 cells per well','NA','Luciferase based ATP assay','0.065 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4384','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human filamin-1 transfected M2 skin melanoma cell line','A7','500 cells per well','NA','Luciferase based ATP assay','0.363 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4385','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human lung metastasis cell line','MALME-3M','1000 cells per well','NA','Luciferase based ATP assay','0.155 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4386','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human malignant melanoma cell line','UACC-257','1000 cells per well','NA','Luciferase based ATP assay','0.370 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4387','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human malignant melanoma cell line','SK-MEL-28','500 cells per well','NA','Luciferase based ATP assay','0.922 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4388','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lymph node metastasis cell line','SKMEL-3','1000 cells per well','NA','Luciferase based ATP assay','1.80 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4389','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human bowes melanoma cell line','HMCB','750 cells per well','NA','Luciferase based ATP assay','6.10 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4390','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human lymph node metastasis cell line','LOX-IMVI','1000 cells per well','NA','Luciferase based ATP assay','6 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4391','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human malignant melanoma cell line','UCSD-24L','500 cells per well','NA','Luciferase based ATP assay','2.25 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4392','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human primary melanoma cell line','A375','250 cells per well','NA','Luciferase based ATP assay','4.43 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4393','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','NCI','Human malignant melanoma cell line','UACC-62','500 cells per well','NA','Luciferase based ATP assay','2.46 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4394','Newcastle disease virus','MTH-68/H','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human lymph node metastasis cell line','RPMI-7951','500 cells per well','NA','Luciferase based ATP assay','8.80 MOI','80% cancer cell death','No','No','NA','No response','NA','ER stress and apoptotic pathway','IFN production increased','NA','26408702'),
  ('OV_4395','Vesicular stomatitis virus','Mutant','RNA','Rhabdoviridae','Virus expressing HIF2alpha, Sox10 and c-Myc gene','No','VSV-HIF2alpha+ VSV-sox10+ VSV-cMYC','No','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for GL261 cell line','5.0E+6 pfu','NA','60% mice survived on day 30, 20% mice survived on day 45 and last mice survived on day 60','Intravenous','NA','AntiPD-1 antibody enhances the IL-17 and IFN-gamma production','NA','26409567'),
  ('OV_4396','Vesicular stomatitis virus','Mutant','RNA','Rhabdoviridae','Virus expressing HIF2alpha, Sox10 and GFP gene','No','VSV-HIF2alpha+ VSV-sox10+ VSV-GFP','No','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for GL261 cell line','5.0E+6 pfu','NA','All mice survived upto day 30 fter that all was dead','Intravenous','NA','AntiPD-1 antibody enhances the IL-17 and IFN-gamma production','NA','26409567'),
  ('OV_4397','Vesicular stomatitis virus','Mutant','RNA','Rhabdoviridae','Virus expressing N-Ras, cytC and TYRP-1 gene','No','VSV-N-Ras+VSV-cytC+ VSV-TYRP-1','No','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for GL261 cell line','5.0E+6 pfu','NA','All mice survived upto day 10 fter that all was dead','Intravenous','NA','AntiPD-1 antibody enhances the IL-17 and IFN-gamma production','NA','26409567'),
  ('OV_4398','Vesicular stomatitis virus','Mutant','RNA','Rhabdoviridae','Virus expressing HIF2alpha, Sox10 and c-Myc gene','No','VSV-HIF2alpha, VSV-Sox10+ VSV-cMyc+antiPD1','No','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for GL261 cell line','5.0E+6 pfu','NA','Mice survived upto day 45','Intravenous','NA','AntiPD-1 antibody enhances the IL-17 and IFN-gamma production','NA','26409567'),
  ('OV_4399','Vesicular stomatitis virus','Mutant','RNA','Rhabdoviridae','Virus expressing HIF2alpha, Sox10 and c-Myc gene','No','VSV-HIF2alpha, VSV-Sox10+ VSV-cMyc+IgG','No','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for GL261 cell line','5.0E+6 pfu','NA','Mice survived upto day 35','Intravenous','NA','AntiPD-1 antibody enhances the IL-17 and IFN-gamma production','NA','26409567'),
  ('OV_4400','Vesicular stomatitis virus','Mutant','RNA','Rhabdoviridae','virus expressing GFP','No','VSV-GFp+anti-GFP','No','NA','NA','NA','NA','NA','NA','NA','NA','C57BL/6 mice xenograft for GL261 cell line','5.0E+6 pfu','NA','Mice survived upto day 12','Intravenous','NA','AntiPD-1 antibody enhances the IL-17 and IFN-gamma production','NA','26409567'),
  ('OV_4401','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a','NA','NA','Statistical method','16.64+/- 1.41','20% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4402','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a','NA','NA','Statistical method','57.46+/- 8.37','50% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4403','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a','NA','NA','Statistical method','96.31+/- 10.76','70% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4404','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a/carbo-15a','NA','NA','Statistical method','16.56+/- 2.78','20% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4405','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a/carbo-15a','NA','NA','Statistical method','52.17+/- 9.68','50% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4406','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a/carbo-15a','NA','NA','Statistical method','90.13+/- 14.42','70% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4407','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma','HT-29','NA','NA','Statistical method','26.80+/- 7.82','20% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4408','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma','HT-29','NA','NA','Statistical method','74.23+/- 18.19','50% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4409','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma','HT-29','NA','NA','Statistical method','127.2+/- 39','70% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4410','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma','HT-29/CP-5c','NA','NA','Statistical method','7.56+/- 1.96','20% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4411','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma','HT-29/CP-5c','NA','NA','Statistical method','26.70+/- 5.90','50% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4412','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma','HT-29/CP-5c','NA','NA','Statistical method','49.95+/- 9.01','70% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4413','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma','HT-29/carbo-15d-1','NA','NA','Statistical method','20.13+/- 10.23','20% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4414','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma','HT-29/carbo-15d-1','NA','NA','Statistical method','48.46+/- 19.03','50% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4415','Adenovirus','ONYX-015','DNA','Adenoviridae','None','Yes','No','No','ATCC','Human colon carcinoma','HT-29/carbo-15d-1','NA','NA','Statistical method','78.27+/- 25.11','70% cancer cell death','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4416','Adenovirus','ONYX-015','DNA','Adenoviridae','None','No','Virus in combination with melphalan (2.5 microgram)','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a','NA','NA','Flow cytometry','20 pfu','3% cancer cell death after day 3','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4417','Adenovirus','ONYX-015','DNA','Adenoviridae','None','No','Virus in combination with melphalan (5 microgram)','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a','NA','NA','Flow cytometry','20 pfu','6% cancer cell death after day 3','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4418','Adenovirus','ONYX-015','DNA','Adenoviridae','None','No','Virus in combination with melphalan (7.5 microgram)','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a','NA','NA','Flow cytometry','20 pfu','10% cancer cell death after day 3','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4419','Adenovirus','ONYX-015','DNA','Adenoviridae','None','No','Virus in combination with melphalan (2.5 microgram)','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a','NA','NA','Flow cytometry','20 pfu','3% cancer cell death after day 3','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4420','Adenovirus','ONYX-015','DNA','Adenoviridae','None','No','Virus in combination with melphalan (5 microgram)','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a','NA','NA','Flow cytometry','20 pfu','15% cancer cell death after day 3','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4421','Adenovirus','ONYX-015','DNA','Adenoviridae','None','No','Virus in combination with melphalan (7.5 microgram)','No','St. Joseph healthcare, London','Human head and neck squamous cell carcinoma','HN-5a','NA','NA','Flow cytometry','20 pfu','25% cancer cell death after day 3','No','No','NA','No response','NA','Increase in apoptosis upto 25%','NA','NA','26429639'),
  ('OV_4422','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.2E+4 cells per well','NA','MTT assay','21:1 particle to pfu','48% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4423','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','ATCC','Human brain cancer cell line','U343','1.2E+4 cells per well','NA','MTT assay','21:1 particle to pfu','25% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4424','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','ATCC','Human brain cancer cell line','U-87 MG','1.2E+4 cells per well','NA','MTT assay','21:1 particle to pfu','52% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4425','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','ATCC','Human liver cancer cell line','Hep3B','1.2E+4 cells per well','NA','MTT assay','21:1 particle to pfu','70% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4426','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','ATCC','Human cervical cancer cell line','C33A','1.2E+4 cells per well','NA','MTT assay','21:1 particle to pfu','50% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4427','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','ATCC','Human cervical cancer cell line','HeLa','1.2E+4 cells per well','NA','MTT assay','21:1 particle to pfu','60% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4428','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','1.2E+4 cells per well','NA','MTT assay','21:1 particle to pfu','48% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4429','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','ATCC','Human breast cancer cell line','MDA-MB-435','1.2E+4 cells per well','NA','MTT assay','21:1 particle to pfu','98% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4430','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','ATCC','Human lung cancer cell line','A549','1.2E+4 cells per well','NA','MTT assay','24:1 particle to pfu','20% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4431','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','ATCC','Human brain cancer cell line','U343','1.2E+4 cells per well','NA','MTT assay','24:1 particle to pfu','20% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4432','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','ATCC','Human brain cancer cell line','U-87 MG','1.2E+4 cells per well','NA','MTT assay','24:1 particle to pfu','30% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4433','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','ATCC','Human liver cancer cell line','Hep3B','1.2E+4 cells per well','NA','MTT assay','24:1 particle to pfu','30% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4434','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','ATCC','Human cervical cancer cell line','C33A','1.2E+4 cells per well','NA','MTT assay','24:1 particle to pfu','48% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4435','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','ATCC','Human cervical cancer cell line','HeLa','1.2E+4 cells per well','NA','MTT assay','24:1 particle to pfu','20% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4436','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','1.2E+4 cells per well','NA','MTT assay','24:1 particle to pfu','1% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4437','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','ATCC','Human breast cancer cell line','MDA-MB-435','1.2E+4 cells per well','NA','MTT assay','24:1 particle to pfu','2% cell survival after 4 days','No','No','NA','No response','NA','NA','NA','NA','26430798'),
  ('OV_4438','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','male athymic nude mice xenograft for A549 (1.0E+7)','5.0E+9 pfu','NA','Tumor volume become below 600 cubic millimeter after 71 days compared to control 1000','Intratumoral','NA','NA','NA','26430798'),
  ('OV_4439','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','male athymic nude mice xenograft for A549 (1.0E+7)','5.0E+9 pfu','NA','Tumor volume become below 100 cubic millimeter after 71 days compared to control 1000','Intratumoral','NA','NA','NA','26430798'),
  ('OV_4440','Vesicular stomatitis virus','RdB','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, no addition of linker','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','male athymic nude mice xenograft for MCF7 (1.0E+7)','5.0E+10 pfu','NA','Tumor volume become below 1500 cubic millimeter after 49 days compared to control 4000','Intratumoral','NA','NA','NA','26430798'),
  ('OV_4441','Vesicular stomatitis virus','RdB-1L-VSVG','RNA','Rhabdoviridae','Virus expressing VSVG epitope, with no dletion in HI-loop, addition of single linker','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','male athymic nude mice xenograft for MCF7 (1.0E+7)','5.0E+10 pfu','NA','Tumor volume become below 600 cubic millimeter after 49 days compared to control 4000','Intratumoral','NA','NA','NA','26430798'),
  ('OV_4442','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN3','4000 to 5000 cells per well','NA','MTS assay','0.03 MOI','78% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4443','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN3','4000 to 5000 cells per well','NA','MTS assay','0.1 MOI','18% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4444','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN3','4000 to 5000 cells per well','NA','MTS assay','0.3 MOI','1% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4445','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN3','4000 to 5000 cells per well','NA','MTS assay','1 MOI','100% cell killing after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4446','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN7','4000 to 5000 cells per well','NA','MTS assay','0.001 MOI','68% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4447','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN7','4000 to 5000 cells per well','NA','MTS assay','0.003 MOI','40% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4448','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN7','4000 to 5000 cells per well','NA','MTS assay','0.01 MOI','22% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4449','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN7','4000 to 5000 cells per well','NA','MTS assay','0.03 MOI','18% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4450','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN7','4000 to 5000 cells per well','NA','MTS assay','0.1 MOI','16% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4451','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN7','4000 to 5000 cells per well','NA','MTS assay','0.3 MOI','16% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4452','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN7','4000 to 5000 cells per well','NA','MTS assay','1 MOI','16% cell survival after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4453','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN465','4000 to 5000 cells per well','NA','MTS assay','0.04 MOI','45% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4454','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN475','4000 to 5000 cells per well','NA','MTS assay','0.04 MOI','45% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4455','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN298','4000 to 5000 cells per well','NA','MTS assay','0.04 MOI','70% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4456','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN1','4000 to 5000 cells per well','NA','MTS assay','0.04 MOI','30% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4457','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN465','4000 to 5000 cells per well','NA','MTS assay','0.11 MOI','30% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4458','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN475','4000 to 5000 cells per well','NA','MTS assay','0.11 MOI','35% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4459','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN298','4000 to 5000 cells per well','NA','MTS assay','0.11 MOI','55% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4460','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN1','4000 to 5000 cells per well','NA','MTS assay','0.11 MOI','20% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4461','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN465','4000 to 5000 cells per well','NA','MTS assay','0.33 MOI','20% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4462','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN475','4000 to 5000 cells per well','NA','MTS assay','0.33 MOI','20% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4463','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN298','4000 to 5000 cells per well','NA','MTS assay','0.33 MOI','50% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4464','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN1','4000 to 5000 cells per well','NA','MTS assay','0.33 MOI','10% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4465','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN465','4000 to 5000 cells per well','NA','MTS assay','1 MOI','15% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4466','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN475','4000 to 5000 cells per well','NA','MTS assay','1 MOI','15% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4467','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN298','4000 to 5000 cells per well','NA','MTS assay','1 MOI','30% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4468','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN1','4000 to 5000 cells per well','NA','MTS assay','1 MOI','5% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4469','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN465','4000 to 5000 cells per well','NA','MTS assay','3 MOI','10% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4470','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN475','4000 to 5000 cells per well','NA','MTS assay','3 MOI','12% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4471','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN298','4000 to 5000 cells per well','NA','MTS assay','3 MOI','25% cell viablity after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4472','Herpes simplex virus','G47-delta-mCherry','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','Human patient','malignant leningioma','MN1','4000 to 5000 cells per well','NA','MTS assay','3 MOI','100% cell killing after 96 hours','No','No','NA','No response','NA','NA','NA','NA','26951380'),
  ('OV_4473','Herpes simplex virus','G47-delta','DNA','Herpesviridae','Deletion mutant for Gamma 34.5, alpha47 and LacZ insertion inactivating ICP6','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice orthotopic xenograft for MN3 cell (75000 cells)','2.0E+6 pfu on day 14 and 25 post tumor cell implantation','NA','Survival time increased from control 80 days to 160 days in virus trated group','Intratumoral','NA','NA','NA','26951380'),
  ('OV_4474','Adenovirus','oAD/DCN-shMet','DNA','Adenoviridae','Adenovirus conjugated with DCN and shMet','Yes','No','No','ATCC','Human lung carcinoma cell line','A549','70% confluence in 24 well plate','NA','MTT assay','1 MOI','65% cancer cell survivalability after 48 hours','No','No','NA','No response','NA','NA','Increased in IL-6 level to 140pg/ml compared to control 20 pg/ml','NA','26951927'),
  ('OV_4475','Adenovirus','oAD/DCN-shMet/PP','DNA','Adenoviridae','Adenovirus conjugated with DCN, shMet and PEGylated at PAMAM','Yes','No','No','ATCC','Human lung carcinoma cell line','A549','70% confluence in 24 well plate','NA','MTT assay','1 MOI','58% cancer cell survivalability after 48 hours','No','No','NA','No response','NA','NA','Increased in IL-6 level to 40pg/ml compared to control 20 pg/ml','NA','26951927'),
  ('OV_4476','Adenovirus','oAD/DCN-shMet/PPE','DNA','Adenoviridae','Adenovirus conjugated with DCN, shMet and Erbitux-conjugated PEGylated at PAMAM','Yes','No','No','ATCC','Human lung carcinoma cell line','A549','70% confluence in 24 well plate','NA','MTT assay','1 MOI','18% cancer cell survivalability after 48 hours','No','No','NA','No response','NA','NA','Increased in IL-6 level to 40pg/ml compared to control 20 pg/ml','NA','26951927'),
  ('OV_4477','Adenovirus','oAD/DCN-shMet','DNA','Adenoviridae','Adenovirus conjugated with DCN and shMet','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','70% confluence in 24 well plate','NA','MTT assay','100 MOI','88% cancer cell survivalability after 48 hours','No','No','NA','No response','NA','NA','Increased in IL-6 level to 140pg/ml compared to control 20 pg/ml','NA','26951927'),
  ('OV_4478','Adenovirus','oAD/DCN-shMet/PP','DNA','Adenoviridae','Adenovirus conjugated with DCN, shMet and PEGylated at PAMAM','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','70% confluence in 24 well plate','NA','MTT assay','100 MOI','85% cancer cell survivalability after 48 hours','No','No','NA','No response','NA','NA','Increased in IL-6 level to 40pg/ml compared to control 20 pg/ml','NA','26951927'),
  ('OV_4479','Adenovirus','oAD/DCN-shMet/PPE','DNA','Adenoviridae','Adenovirus conjugated with DCN, shMet and Erbitux-conjugated PEGylated at PAMAM','Yes','No','No','ATCC','Human breast cancer cell line','MCF-7','70% confluence in 24 well plate','NA','MTT assay','100 MOI','82% cancer cell survivalability after 48 hours','No','No','NA','No response','NA','NA','Increased in IL-6 level to 40pg/ml compared to control 20 pg/ml','NA','26951927'),
  ('OV_4480','Adenovirus','oAD/DCN-shMet','DNA','Adenoviridae','Adenovirus conjugated with DCN and shMet','Yes','No','No','ATCC','Human breast cancer cell line','HDF','70% confluence in 24 well plate','NA','MTT assay','20 MOI','90% cancer cell survivalability after 48 hours','No','No','NA','No response','NA','NA','Increased in IL-6 level to 140pg/ml compared to control 20 pg/ml','NA','26951927'),
  ('OV_4481','Adenovirus','oAD/DCN-shMet/PP','DNA','Adenoviridae','Adenovirus conjugated with DCN, shMet and PEGylated at PAMAM','Yes','No','No','ATCC','Human breast cancer cell line','HDF','70% confluence in 24 well plate','NA','MTT assay','20 MOI','90% cancer cell survivalability after 48 hours','No','No','NA','No response','NA','NA','Increased in IL-6 level to 40pg/ml compared to control 20 pg/ml','NA','26951927'),
  ('OV_4482','Adenovirus','oAD/DCN-shMet/PPE','DNA','Adenoviridae','Adenovirus conjugated with DCN, shMet and Erbitux-conjugated PEGylated at PAMAM','Yes','No','No','ATCC','Human breast cancer cell line','HDF','70% confluence in 24 well plate','NA','MTT assay','20 MOI','90% cancer cell survivalability after 48 hours','No','No','NA','No response','NA','NA','Increased in IL-6 level to 40pg/ml compared to control 20 pg/ml','NA','26951927'),
  ('OV_4483','Herpes simplex virus','RH2','DNA','Herpesviridae','Mutant for Gamma 34.5 gene and gB gene','Yes','No','No','NA','Murine squamous cell carcinoma','SCCVII','NA','NA','MTT assay','10 MOI','70% cell survival after 12 hours','No','No','NA','No response','NA','Virus induced apoptosis','Increased extracellular ATP and HMGB1, indicating immunogenic cell death','NA','26987291'),
  ('OV_4484','Herpes simplex virus','RH2','DNA','Herpesviridae','Mutant for Gamma 34.5 gene and gB gene','Yes','No','No','NA','Murine squamous cell carcinoma','SCCVII','NA','NA','MTT assay','10 MOI','60% cell survival after 12 hours','No','No','NA','No response','NA','Virus induced apoptosis','Increased extracellular ATP and HMGB1, indicating immunogenic cell death','NA','26987291'),
  ('OV_4485','Herpes simplex virus','RH2','DNA','Herpesviridae','Mutant for Gamma 34.5 gene and gB gene','Yes','No','No','NA','Murine squamous cell carcinoma','SCCVII','NA','NA','MTT assay','10 MOI','50% cell survival after 12 hours','No','No','NA','No response','NA','Virus induced apoptosis','Increased extracellular ATP and HMGB1, indicating immunogenic cell death','NA','26987291'),
  ('OV_4486','Herpes simplex virus','RH2','DNA','Herpesviridae','Mutant for Gamma 34.5 gene and gB gene','Yes','No','No','NA','Murine squamous cell carcinoma','SCCVII','NA','NA','MTT assay','100 MOI','50% cell survival after 12 hours','No','No','NA','No response','NA','Virus induced apoptosis','Increased extracellular ATP and HMGB1, indicating immunogenic cell death','NA','26987291'),
  ('OV_4487','Herpes simplex virus','RH2','DNA','Herpesviridae','Mutant for Gamma 34.5 gene and gB gene','Yes','No','No','NA','Murine squamous cell carcinoma','SCCVII','NA','NA','MTT assay','100 MOI','40% cell survival after 12 hours','No','No','NA','No response','NA','Virus induced apoptosis','Increased extracellular ATP and HMGB1, indicating immunogenic cell death','NA','26987291'),
  ('OV_4488','Herpes simplex virus','RH2','DNA','Herpesviridae','Mutant for Gamma 34.5 gene and gB gene','Yes','No','No','NA','Murine squamous cell carcinoma','SCCVII','NA','NA','MTT assay','100 MOI','30% cell survival after 12 hours','No','No','NA','No response','NA','Virus induced apoptosis','Increased extracellular ATP and HMGB1, indicating immunogenic cell death','NA','26987291'),
  ('OV_4489','Herpes simplex virus','RH2','DNA','Herpesviridae','Mutant for Gamma 34.5 gene and gB gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','C3H mice subcutaneous implanted for SCCVII (1.0E+6)','50 microliter of RH2 virus, 3 times at interval of 2 days','NA','Tumor volume was less than 1587 cubic mm in treated mice compared to control 2996 cubic mm after 25 days','Intratumoral','Virus induced apoptosis','Increased extracellular ATP and HMGB1, indicating immunogenic cell death','NA','26987291'),
  ('OV_4490','Newcastle disease virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','0.0001 MOI','50% cell viablity after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4491','Newcastle disease virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','0.01 MOI','30% cell viablity after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4492','Newcastle disease virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','0.1 MOI','100% cell death after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4493','Newcastle disease virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','1 MOI','100% cell death after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4494','Newcastle disease virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','10 MOI','100% cell death after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4495','Newcastle disease virus','73T-S-Km','RNA','Paramyxoviridae','Insertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','0.0001 MOI','80% cell viablity after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4496','Newcastle disease virus','73T-S-Km','RNA','Paramyxoviridae','Insertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','0.01 MOI','38% cell viablity after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4497','Newcastle disease virus','73T-S-Km','RNA','Paramyxoviridae','Insertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','0.1 MOI','15% cell viablity after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4498','Newcastle disease virus','73T-S-Km','RNA','Paramyxoviridae','Insertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','1 MOI','100% cell death after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4499','Newcastle disease virus','73T-S-Km','RNA','Paramyxoviridae','Insertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','10 MOI','100% cell death after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4500','Newcastle disease virus','73T-R-198','RNA','Paramyxoviridae','Insertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','0.0001 MOI','50% cell viablity after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4501','Newcastle disease virus','73T-R-198','RNA','Paramyxoviridae','Insertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','0.01 MOI','20% cell viablity after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4502','Newcastle disease virus','73T-R-198','RNA','Paramyxoviridae','Insertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','0.1 MOI','100% cell death after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4503','Newcastle disease virus','73T-R-198','RNA','Paramyxoviridae','Insertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','1 MOI','100% cell death after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4504','Newcastle disease virus','73T-R-198','RNA','Paramyxoviridae','Insertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','ATCC','Human fibroblast sarcoma cell line','HT1080','5.0E+3 cells per well','NA','Cell titer glo kit','10 MOI','100% cell death after 72 hours','No','No','NA','No response','NA','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4505','Newcastle disease virus','wild type','RNA','Paramyxoviridae','None','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for HT1080 (5.0E+6)','2.0E+7 pfu','NA','Tumor volume reduced to 300 cubic mm after 25 days compared to control 800 cubic mm','Intratumoral','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4506','Newcastle disease virus','73T-S-Km','RNA','Paramyxoviridae','Insertion of HNKMKS sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for HT1080 (5.0E+6)','2.0E+7 pfu','NA','Tumor volume reduced to below 100 cubic mm after 25 days compared to control 800 cubic mm','Intratumoral','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4507','Newcastle disease virus','73T-R-198','RNA','Paramyxoviridae','Insertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for HT1080 (5.0E+6)','2.0E+7 pfu','NA','Tumor volume reduced to 300 cubic mm after 25 days compared to control 800 cubic mm','Intratumoral','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4508','Newcastle disease virus','73T-R-198','RNA','Paramyxoviridae','Insertion of HNRTKR sequence in fusogenic site between 111 -116 nucleotide','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Athymic nude mice xenograft for HT1080 (5.0E+6)','1.0E+8 pfu','NA','Tumor volume reduced to below 500 cubic mm compared to control 1000 cubic mm after 25 days','Intravenous','NA','Induced expression of Type 1 IFN, NK cells and macrophages','NA','27009956'),
  ('OV_4509','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','Yes','No','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1 VP/cell','100% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4510','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.001mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1 VP/cell','75% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4511','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.0025mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1 VP/cell','75% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4512','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.005mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1 VP/cell','62% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4513','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','Yes','No','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','10 VP/cell','90% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4514','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.001mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','10 VP/cell','70% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4515','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.0025mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','10 VP/cell','70% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4516','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.005mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','10 VP/cell','70% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4517','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','Yes','No','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','100 VP/cell','40% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4518','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.001mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','100 VP/cell','35% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4519','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.0025mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','100 VP/cell','30% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4520','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.005mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','100 VP/cell','35% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4521','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','Yes','No','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1000 VP/cell','18% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4522','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.001mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1000 VP/cell','15% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4523','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.0025mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1000 VP/cell','15% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4524','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with 4-HP-CP (0.005mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1000 VP/cell','15% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4525','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','Yes','No','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1 VP/cell','100% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4526','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with Cyclophosphamide (0.0075mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1 VP/cell','90% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4527','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with Cyclophosphamide (0.05mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1 VP/cell','80% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4528','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','Yes','No','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','10 VP/cell','80% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4529','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with Cyclophosphamide (0.0075mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','10 VP/cell','70% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4530','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with Cyclophosphamide (0.05mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','10 VP/cell','62% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4531','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','Yes','No','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','100 VP/cell','40% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4532','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with Cyclophosphamide (0.0075mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','100 VP/cell','40% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4533','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with Cyclophosphamide (0.05mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','100 VP/cell','40% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4534','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','Yes','No','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1000 VP/cell','20% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4535','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with Cyclophosphamide (0.0075mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1000 VP/cell','20% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4536','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with Cyclophosphamide (0.05mg/ml)','No','ATCC','Human breast cancer triple negative cell line','MDA-MB-436','1000 cells per well','NA','MTS assay','1000 VP/cell','20% cancer cell survival after 5 days','No','No','NA','No response','NA','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4537','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Female nude NMRI mice xenograft for MDA-MB-436 (5.0E+6)','7.0E+9 pfu on day 1,4,8,15,29 and 43','NA','Tumor volume reduced to 1400 cubic mm after 36 days compared to contro 2200 cubic mm','Intratumoral','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4538','Adenovirus','Ad5/3-D24-GMCSF','DNA','Adenoviridae','Ad5/3-delta24 has a 24 base-pair deletion in constant region 2 of the E1A gene and armed wirh human GMCSF','No','Virus in combination with cyclophospahamide (20mg/kg), intraperionoeal','No','NA','NA','NA','NA','NA','NA','NA','NA','Female nude NMRI mice xenograft for MDA-MB-436 (5.0E+6)','7.0E+9 pfu on day 1,4,8,15,29 and 43','NA','Tumor volume reduced to 200 cubic mm after 61 days compared to contro 2200 cubic mm','Intratumoral','NA','Virus induced tumor specific T-cell response','NA','27057453'),
  ('OV_4539','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4540','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','97% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4541','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','97% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4542','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4543','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4544','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','82% cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4545','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','82% cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4546','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','72% cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4547','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','72% cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4548','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','60% cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4549','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','60% cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4550','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','50% cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4551','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','40% cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4552','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','42% cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4553','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','42% cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4554','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','A549','5.0E+4 cells per well','NA','MTT assay','10 MOI','35% cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4555','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cancer cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4556','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4557','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4558','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cancer cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4559','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4560','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4561','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4562','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4563','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4564','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4565','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4566','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4567','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','78% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4568','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','82% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4569','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','80% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4570','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H460','5.0E+4 cells per well','NA','MTT assay','10 MOI','62% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4571','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4572','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4573','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4574','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4575','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4576','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4577','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','82% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4578','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','72% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4579','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','70% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4580','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','70% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4581','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','62% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4582','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','50% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4583','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','60% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4584','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','60% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4585','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','58% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4586','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1299','5.0E+4 cells per well','NA','MTT assay','10 MOI','42% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4587','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4588','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4589','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4590','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cell survival after 24 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4591','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4592','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4593','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','100% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4594','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','90% cancer cell survival after 48 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4595','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','80% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4596','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','80% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4597','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','80% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4598','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','70% cancer cell survival after 72 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4599','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','80% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4600','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','80% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4601','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','80% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4602','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','Shanghai cell collection','Human lung carcinoma cell line','NCI-H1975','5.0E+4 cells per well','NA','MTT assay','10 MOI','70% cancer cell survival after 96 hours','No','No','NA','No response','NA','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4603','Adenovirus','CD55-MnSOD','DNA','Adenoviridae','virus containing MnSOD gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice xenograft for A549 cell (5.0E+6)','5.0E+8 pfu','NA','Tumor volume reduced to 300 cubic mm comapred to control 700 cubic mm after 40 days','Intratumoral','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4604','Adenovirus','CD55-TRAIL','DNA','Adenoviridae','virus containing TRAIL gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice xenograft for A549 cell (5.0E+6)','5.0E+8 pfu','NA','Tumor volume reduced to 220 cubic mm comapred to control 700 cubic mm after 40 days','Intratumoral','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4605','Adenovirus','CD55-TRAIL+ CD55-MnSOD','DNA','Adenoviridae','virus containing TRAIl and MnSOD gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice xenograft for A549 cell (5.0E+6)','5.0E+8 pfu','NA','Tumor volume reduced to 200 cubic mm comapred to control 700 cubic mm after 40 days','Intratumoral','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4606','Adenovirus','CD55-TRAIL-IETD-MnSOD','DNA','Adenoviridae','Virus having TRAIL, MnSOD gene linked via IETD caspase 8 cleavage site','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','BALB/c mice xenograft for A549 cell (5.0E+6)','5.0E+8 pfu','NA','Tumor volume reduced to below 100 cubic mm comapred to control 700 cubic mm after 40 days','Intratumoral','Virus induced apoptosis','NA','NA','27080225'),
  ('OV_4607','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','1 VP per cell','100% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4608','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','10 VP per cell','100% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4609','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','100 VP per cell','70% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4610','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','1 VP per cell','100% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4611','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','10 VP per cell','50% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4612','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','100 VP per cell','10% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4613','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','1 VP per cell','70% cell viablity after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4614','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','10 VP per cell','58 cell viablity after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4615','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','100 VP per cell','10% cell viablity after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4616','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','1 VP per cell','100% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4617','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','10 VP per cell','100% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4618','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','VU university medical centre, Netherland','Human neck and squamous cell carcinoma cell line','93VU147T','3000 cells per well','NA','MTT assay','100 VP per cell','100% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4619','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','1 VP per cell','100% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4620','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','10 VP per cell','100% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4621','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','100 VP per cell','100% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4622','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','1 VP per cell','100% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4623','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','10 VP per cell','100% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4624','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','100 VP per cell','40% cell viablity after 3 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4625','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','1 VP per cell','80% cell viablity after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4626','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','10 VP per cell','80% cell viablity after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4627','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','100 VP per cell','70% cell viablity after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4628','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','1 VP per cell','100% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4629','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','10 VP per cell','100% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4630','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','University of pitsburgh','Human neck and squamous cell carcinoma cell line','UPCI SCC 090','3000 cells per well','NA','MTT assay','100 VP per cell','100% cell killing after 7 days','No','No','NA','No response','NA','NA','NA','NA','27086483'),
  ('OV_4631','Adenovirus','Ad5/3-delata 24','DNA','Adenoviridae','Mutation in delta E3 and delta 24 gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Female athymic nude mice xenograft for UPCI SCC 090 (2.0E+6)','3.5E+11 pfu','NA','Complete ereduction in tumor volume after 30 days','Intratumoral','NA','NA','NA','27086483'),
  ('OV_4632','Adenovirus','Ad5/3-CB016','DNA','Adenoviridae','Mutation in delta E3 gene','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','Female athymic nude mice xenograft for UPCI SCC 090 (2.0E+6)','3.5E+11 pfu','NA','Complete ereduction in tumor volume after 30 days','Intratumoral','NA','NA','NA','27086483'),
  ('OV_4633','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CF33','NA','NA','WST-1 assay','2 MOI','50% cell viability after 2 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4634','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CF33','NA','NA','WST-1 assay','2 MOI','30% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4635','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CF33','NA','NA','WST-1 assay','2 MOI','35% cell viability after 6 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4636','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CF33','NA','NA','WST-1 assay','2 MOI','30% cell viability after 8 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4637','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CTBm','NA','NA','WST-1 assay','2 MOI','100% cell viability after 2 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4638','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CTBm','NA','NA','WST-1 assay','2 MOI','80% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4639','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CTBm','NA','NA','WST-1 assay','2 MOI','60% cell viability after 6 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4640','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CTBm','NA','NA','WST-1 assay','2 MOI','50% cell viability after 8 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4641','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CHMm','NA','NA','WST-1 assay','2 MOI','100% cell viability after 2 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4642','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CHMm','NA','NA','WST-1 assay','2 MOI','40% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4643','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CHMm','NA','NA','WST-1 assay','2 MOI','40% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4644','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','Univesity of Tokyo Japan','Canine mammary cancer','CHMm','NA','NA','WST-1 assay','2 MOI','40% cell viability after 4 days','No','No','NA','No response','NA','NA','NA','NA','27093696'),
  ('OV_4645','Measles virus','rMV-SLAMblind','RNA','Paramyxoviridae','R533A substitution was introduced into pMV-HL(7+) and then transfected to vero cell line to produce virus particle','Yes','No','No','NA','NA','NA','NA','NA','NA','NA','NA','SCID mice xenograft for CF33 cells','1.0E+6 TCID50','NA','Reduction in tumor volume below 100 cubic mm after 50 days compared to control 700 cubic mm','Intratumoral','NA','NA','NA','27093696'),
  ('OV_4646','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (0.5 micromolar/litre)','No','St. Louis university','Cotton rat tumor cell line','LCRT','1.0E+5 cells per ml','NA','MTT assay','1 MOI','87% cell viablity after 2 days, additive effect','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119103'),
  ('OV_4647','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (0.5 micromolar/litre)','No','St. Louis university','Cotton rat tumor cell line','LCRT','1.0E+5 cells per ml','NA','MTT assay','3 MOI','80% cell viablity after 2 days, additive effect','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119103'),
  ('OV_4648','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (0.5 micromolar/litre)','No','St. Louis university','Cotton rat tumor cell line','LCRT','1.0E+5 cells per ml','NA','MTT assay','5 MOI','56% cell viablity after 2 days, additive effect','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119103'),
  ('OV_4649','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (1.0 micromolar/litre)','No','St. Louis university','Cotton rat tumor cell line','LCRT','1.0E+5 cells per ml','NA','MTT assay','1 MOI','74% cell viablity after 2 days, additive effect','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119103'),
  ('OV_4650','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (1.0 micromolar/litre)','No','St. Louis university','Cotton rat tumor cell line','LCRT','1.0E+5 cells per ml','NA','MTT assay','3 MOI','79% cell viablity after 2 days, additive effect','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119103'),
  ('OV_4651','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (1.0 micromolar/litre)','No','St. Louis university','Cotton rat tumor cell line','LCRT','1.0E+5 cells per ml','NA','MTT assay','5 MOI','56% cell viablity after 2 days, additive effect','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119103'),
  ('OV_4652','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (3.0 micromolar/litre)','No','St. Louis university','Cotton rat tumor cell line','LCRT','1.0E+5 cells per ml','NA','MTT assay','1 MOI','59% cell viablity after 2 days, additive effect','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119103'),
  ('OV_4653','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (3.0 micromolar/litre)','No','St. Louis university','Cotton rat tumor cell line','LCRT','1.0E+5 cells per ml','NA','MTT assay','3 MOI','60% cell viablity after 2 days, additive effect','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119103'),
  ('OV_4654','Bovine herpesvirus','BHV-1','DNA','Herpesviridae','None','No','Virus in combination with 5-AZa (3.0 micromolar/litre)','No','St. Louis university','Cotton rat tumor cell line','LCRT','1.0E+5 cells per ml','NA','MTT assay','5 MOI','60% cell viablity after 2 days, additive effect','No','No','NA','No response','NA','NA','Induce antitumor immune response','NA','27119103'),
